Page last updated: 2024-09-04

docetaxel anhydrous and Cancer of Head

docetaxel anhydrous has been researched along with Cancer of Head in 398 studies

Research

Studies (398)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	23 (5.78)	18.2507
2000's	136 (34.17)	29.6817
2010's	196 (49.25)	24.3611
2020's	43 (10.80)	2.80

Authors

Authors	Studies
Brett, ML; Colley, HE; Coole, SF; Danson, SJ; Dossetter, AG; Griffen, EJ; Harrison, J; Jackson, LV; Jennings, LR; Lockey, PM; Mason, DP; Muthana, M; Norman, D; Thompson, MJ; Tulasi, V; Williams, L; Wong, M	1
Harabuchi, Y; Hayashi, R; Hayashi, T; Katada, A; Kishibe, K; Komatsuda, H; Kono, M; Kumai, T; Takahara, M; Wakisaka, R; Yamaki, H	1
Aretin, MB; Czerny, C; Fuereder, T; Heller, G; Minichsdorfer, C; Mittlboeck, M; Müllauer, L; Oberndorfer, F; Putz, EM; Schwarz-Nemec, U; Wagner, C	1
Dietz, A; Fietkau, R; Frickhofen, N; Gauler, T; Goerling, U; Große-Thie, C; Grünwald, V; Guntinas-Lichius, O; Haxel, B; Keilholz, U; Klinghammer, K; Knipping, S; Knoedler, M; Lindeman, HW; Martus, P; Maschmeyer, G; Zipfel, M	1
Chandrasekharan, A; Dhumal, S; Ghosh Laskar, S; Kolkur, M; Kumar Chinthala, S; Menon, N; Noronha, V; Patil, VM; Prabhash, K; Simha, V; Talreja, V; Waratkar, G	1
Dong, MJ; Fu, JY; Li, J; Yue, XH; Zhang, CP	1
Ding, H; Li, R; Tian, S; Wang, S; Wang, X; Wu, C; Ye, L; Ying, H; Zhou, L; Zhu, Y	1
Chen, L; Duan, S; Gao, J; Gu, Z; Kang, X; Sun, S; Tian, Z; Wang, C; Wang, L; Wang, R; Wang, Y; Wu, Q; Wu, Y; Yang, G; Yao, Y; Zhang, J; Zhang, Z; Zhao, Z; Zhu, G	1
Alone, M; Bhattacharjee, A; Dhumal, S; Kumar, S; Menon, N; Nawale, KP; Noronha, V; Patil, V; Prabhash, K; Waratkar, G	1
Cirauqui, B; Cruz-Hernández, JJ; García Girón, C; Grau, JJ; Hitt, R; Iglesias Docampo, L; Lozano, A; Martínez-Trufero, J; Mesía, R; Morillo, EDB; Rubió-Casadevall, J; Taberna, M; Vázquez Estévez, S	1
Chen, X; Fang, L; Guo, R; Liu, H; Pu, Y; Su, X; Yu, X; Zhang, H	1
Chang, LC; Chang, WC; Chen, JH; Fan, CC; Hsieh, CY; Huang, YW; Lin, CC; Lin, CY; Tsou, YA	1
Chang, KM; Hung, CJ; Kang, BH; Kang, YY; Lee, CC; Yin, CH	1
Ariga, H; Ikeda, A; Katagiri, K; Kusaka, T; Miyaguchi, J; Ohashi, YU; Oikawa, SI; Saito, D; Shiga, K; Tanno, K; Tsuchida, K	1
Agarwal, A; Alone, M; Balaji, A; Bhattacharjee, A; Budrukkar, A; Chaturvedi, P; Chaukar, D; Choudhary, J; Dey, S; Ghosh-Laskar, S; Jobanputra, K; Kapu, V; Karuvandan, N; Krishna, MR; Kumar, S; Mahajan, A; Mathrudev, V; Menon, N; Nair, S; Nawale, K; Noronha, V; Pai, PS; Pathak, S; Patil, VM; Peelay, Z; Pendse, S; Prabhash, K; Purandare, N; Puranik, A; Rai, R; Ravind, R; Reddy Yallala, M; Sahu, H; Shetty, A; Singh, A; Swain, M; Thiagarajan, S	1
De Felice, F	1
Hu, J; Liu, J; Sun, L; Yao, X; Zhang, Y	1
Chen, X; Hata, M; Hayashi, Y; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Yamanaka, S	1
Dunst, J; Schmalz, C	1
Fujita, T; Furukawa, T; Iritani, K; Kakigi, A; Kiyota, N; Miyawaki, D; Nibu, KI; Sasaki, R; Shinomiya, H; Tatehara, S; Teshima, M; Uehara, N; Yamada, A	1
Inohara, H; Ito, T; Tsujimoto, T; Wasa, M	1
Fietkau, R; Frey, B; Gaipl, US; Gehre, S; Gostian, AO; Grottker, F; Hecht, M; Jost, T; Reichardt, CM; Rieckmann, T; Rückert, M; Sengedorj, A	1
Ahn, MJ; Burtness, B; Cohen, EEW; Dinis, J; Ge, J; Harrington, KJ; Lerman, N; Licitra, L; Lin, J; Mach, N; Machiels, JP; Mehra, R; Soria, A; Soulières, D; Swaby, RF; Tourneau, CL	1
Lin, YS; Liu, YH	1
Hayashi, Y; Hibi, H; Sato, K; Watanabe, K; Yoshimi, R	1
Agaimy, A; Fietkau, R; Haderlein, M; Hecht, M; Iro, H; Kitzsteiner, C; Kuwert, T; Müller, S; Schmidt, D; Semrau, S; Traxdorf, M	1
Chan, IS; Lee, WL; Wang, PH	1
Bukhari, N; Haider, G; Hussain, S; Mehar, K; Memon, P; Nouman, M; Nouman, R; Pavan, B; Rahool, R; Sami, A; Shaikh, MR; Yousuf, A; Zahoor, S	1
Ahn, MJ; Ahn, YC; Baek, CH; Chung, MK; Hong, J; Jeong, HS; Lim, SH; Oh, D; Park, K; Son, YI; Sun, JM	1
A Moez, M; Abo-Madyan, Y; Atef, H; Mashhour, K; Selim, A; Zawam, H	1
Lee, J; Roh, JL; Shin, D; You, JH	1
Hamauchi, S; Kawakami, T; Mori, K; Ogawa, H; Onitsuka, T; Onoe, T; Onozawa, Y; Shirasu, H; Yokota, T	1
Baste, N; Berrocal-Jaime, A; Cruz-Hernández, JJ; Cunquero-Tomas, AJ; Del Barco-Morillo, E; García-Girón, C; Grau, JJ; Guix, M; Hitt, R; Iglesias, L; Lambea-Sorrosal, J; León-Vintró, X; López-Pousa, A; Martínez-Trufero, J; Ocaña, A	1
Ahn, HK; Choi, JH; Kang, EJ; Keam, B; Kim, HR; Kim, JS; Kim, MK; Kim, SB; Kwon, JH; Lee, KE; Lee, KW; Lee, YG; Park, KU; Shin, SH; Yun, HJ	1
Hsieh, CY; Hua, CH; Lein, MY; Lin, CC; Lin, CY; Lin, YJ; Tsai, MH; Wang, YC; Yang, SN	1
Botticelli, A; Cerbelli, B; Cirillo, A; Corsi, A; De Vincentiis, M; Di Gioia, C; Marchetti, P; Mezi, S; Polimeni, A; Pomati, G; Roberto, M; Tombolini, V; Valentini, V; Vullo, F	1
Argiris, A; Cella, D; Forastiere, AA; Lee, JW; Oswald, LB; Webster, KA	1
Hirayama, A; Hirose, F; Iwata, S; Kawabata, Y; Oike, A; Osaki, A; Sanematsu, K; Shigemura, N; Takai, S; Wada, N; Watanabe, Y; Yamada, Y; Yamazoe, J	1
Hwang, M; Seiwert, TY	1
Chien, CY; Chou, MH; Chuang, HC; Fang, FM; Huang, TL; Kao, YH; Lin, IC; Lin, YT; Tsai, MH	1
Ahn, HK; Choi, JH; Kang, EJ; Keam, B; Kim, HJ; Kim, HR; Kim, JS; Kim, MK; Kim, SB; Lee, KE; Lee, KW; Lee, YG; Park, KU; Shin, SH; Yun, HJ	1
Altorjai, G; Berghold, A; Burian, M; De Vries, A; Füreder, T; Greil, R; Hackl, J; Hartl, M; Keil, F; Mayrbäurl, B; Melchardt, T; Pecherstorfer, M; Riedl, R; Schuster, J	1
Gota, V; Gurjar, M; Joshi, A; Mehta, P; Nookala, M; Noronha, V; Patil, A; Patil, M; Patil, V; Prabhash, K; Shriyan, B	1
Aladelusi, TO; Ju, W; Sun, W; Zhang, Z; Zhao, T; Zhong, L; Zhu, D	1
El-Haggar, S; Ghonaim, E; Gohar, S	1
Abdeddaim, C; Fortpied, C; Remenár, É; Stewart, JS; Szturz, P; van Herpen, CML; Vermorken, JB; Vinches, M	1
Alterio, D; Cossu Rocca, M; Dicuonzo, S; Fanetti, G; Jereczek-Fossa, BA; Marvaso, G; Nole', F; Preda, L; Russell-Edu, W; Verri, E; Zorzi, S	1
Chung, IJ; Joo, YE; Kim, SA; Lee, DH; Lee, JK; Lee, KH; Lim, SC; Park, YL; Yoon, TM	1
Albers, AE; Fichtner, I; Hoffmann, J; Keilholz, U; Klinghammer, K; Leser, U; Otto, R; Raguse, JD; Tinhofer, I	1
Arai, Y; Chiba, Y; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Tanabe, T; Yabuki, K	1
Avgeris, M; Awada, A; Degardin, M; Fortpied, C; Germà-Lluch, JR; Giurgea, L; Goutas, N; Herman, L; Kienzer, HR; Koutsodontis, G; Kroupis, C; Langendijk, JA; Licitra, L; Menis, J; Pateras, IS; Psyrri, A; Remenár, É; van Herpen, CML; Vermorken, JB	1
Arita, T; Asai, J; Katoh, N; Miyashita, A; Takenaka, H; Taura, M; Wada, M	1
Borel, C; Burgy, M; Leblanc, J	1
Bernstein, JM; Bonington, SC; Carrington, BM; Homer, JJ; Kershaw, LE; Lowe, NM; Mais, K; Slevin, NJ; West, CM; Withey, SB	1
Chen, J; Chen, QQ; Liu, X; Peng, XH; Peng, XY; Qi, J; Tan, JJ; Wang, F; Yu, B; Zeng, FF	1
Ahn, MJ; Chang, WJ; Choi, MK; Hong, JY; Jung, HA; Kim, HS; Kim, MJ; Kim, SM; Park, K; Sun, JM	1
Wollenberg, B	1
Ahn, MJ; Burtness, B; Cheng, J; Cohen, EEW; Dinis, J; Harrington, KJ; Le Tourneau, C; Licitra, L; Mach, N; Machiels, JP; Mehra, R; Soria, A; Soulières, D; Swaby, RF; Zhang, P	1
Lindemann, A; Myers, JN; Osman, AA; Patel, AA; Takahashi, H; Takahashi, Y; Tanaka, N; Zhao, M	1
Harari, PM; Rosenthal, DI; Wu, Q; Zhang, QE	1
Killock, D	1
Berliner, C; Bier, J; Bohlen, M; Busch, C-; Bußmann, L; Forterre, F; Münscher, A; Sehner, S	1
Cocks, K; Contente, M; DeRosa, M; Shaw, JW; Simpson, S; Taylor, FC	1
Bacay, A; Bakst, RL; Catalano, PJ; Chau, NG; Gupta, V; Haddad, RI; Hanna, GJ; Mahmood, U; Margalit, DN; McHugh, P; Misiukiewicz, KJ; Posner, M; Rabinowits, G; Rath, L; Rawal, B; Schoenfeld, JD; Tishler, RB	1
Bernadach, M; Biau, J; Dillies, AF; Durando, X; Kwiatkowski, F; Lapeyre, M; Miroir, J; Moreau, J; Pham-Dang, N; Saroul, N	1
Ikari, Y; Imanishi, Y; Ito, F; Mikoshiba, T; Nakahara, N; Ogawa, K; Ozawa, H; Saito, S; Sekimizu, M; Watanabe, Y	1
Christiansen, H; Hermann, RM	1
Fayette, J; Gau, M; Karabajakian, A; Neidhardt, EM; Reverdy, T	1
Fukushima, H; Mitani, H; Nakano, K; Sasaki, T; Seto, A; Shimbashi, W; Takahashi, S; Yonekawa, H	1
Fury, MG; Haque, S; Heguy, A; Ho, AL; Katabi, N; Nwankwo, O; Pfister, DG; Sherman, E; Sima, C; Tsai, F; Xiao, H	1
Argenone, A; Caponigro, F; Daponte, A; Fulciniti, F; Ionna, F; Longo, F; Muto, P; Perri, F; Sandomenico, F	1
Arnold, D; Dietz, A; Eberhardt, W; Gauler, TC; Gruenwald, V; Hennemann, B; Hofele, C; Jordan, WO; Keilholz, U; Knoedler, M; Matzdorff, A; Schroeder, M; Weissinger, F	1
Hansen, AR; Siu, LL	1
Argiris, A; Burtness, B; Forastiere, AA; Ghebremichael, M; Gilbert, J; Kolesar, JM; Lee, JW; Sachidanandam, K	1
Hanai, N; Harata, I; Hasegawa, Y; Hirakawa, H; Miyazaki, T; Okamoto, H; Ozawa, T; Suzuki, A	1
Bae, WK; Cho, IS; Cho, SH; Chung, IJ; Chung, WK; Han, HS; Hwang, JE; Lee, JK; Lee, KH; Lim, SC; Shim, HJ; Song, EK; Yun, HJ	1
Aderhold, C; Birk, R; Erben, P; Faber, A; Hofheinz, RD; Hörmann, K; Sauter, A; Schultz, JD; Sommer, JU; Stern-Straeter, J; Umbreit, C	1
Baykara, M; Benekli, M; Bora, H; Buyukberber, S; Coskun, U; Dane, F; Demirci, U; Kaplan, MA; Ozturk, B; Unsal, DK	1
Adkins, D; Clark, J; Haddad, R; Jaffa, Z; Limaye, S; O'Neill, A; Posner, M; Riley, S; Zhao, S	1
Cho, H; Inohara, H; Nakahara, S; Takenaka, Y; Yamamoto, M; Yamamoto, Y	1
Dietz, A; Dimitrova, K; Mozet, C; Stoehr, M; Wichmann, G	1
Aderhold, C; Faber, A; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, JD; Sommer, JU; Stern-Sträter, J; Umbreit, C	1
Atrash, F; Billan, S; Doweck, I; Haim, N; Kaidar-Person, O; Kuten, A; Ronen, O	1
Beitler, JJ; Chen, AY; Chen, Z; Chen, ZG; Eggers, C; Grist, WJ; Khuri, FR; Kim, S; Magliocca, KR; Marcus, AI; Muller, S; Owonikoko, TK; Phelan, V; Ramalingam, SS; Saba, NF; Sarlis, NJ; Shin, DM	1
Caudell, JJ; Elci, O; Ganeshan, B; Graham, CM; Griswold, ME; Hamilton, RD; Khan, MA; Pitman, K; Smith, AD; Zhang, H; Zhang, X	1
Coyle, C; Dyker, KE; Karakaya, E; Prestwich, RJ; Sen, M; Teo, M; Young, CA	1
Daiko, H; Ebihara, M; Fujii, S; Hayashi, R; Miyazaki, M; Sakuraba, M; Shinozaki, T; Suzuki, K; Tahara, M; Zenda, S	1
Chen, L; Feldman, LE; Garnett, A; Herman, LC; Smith, B; Spiotto, MT; Weichselbaum, RR	1
Denaro, N; Merlano, MC; Russi, EG	1
Fajdiga, I; Gale, N; Grašič Kuhar, C; Jančar, B; Kadivec, M; Karner, K; Kocjan, BJ; Poljak, M; Strojan, P; Zakotnik, B; Žumer, B	1
Berrocal, A; Brandariz Castelo, JA; Cruz-Hernández, JJ; García-Girón, C; Grau, JJ; Hitt, R; Irigoyen, A; López-Pousa, A; Martínez-Trufero, J; Sastre, J; Verger, E	1
Bechmann, I; Dietz, A; Gerlach, MM; Kubick, C; Lordick, F; Merz, F; Wichmann, G; Wittekind, C	1
Fusi, A; Keilholz, U; Klinghammer, K; Knödler, M; Nonnenmacher, A; Pfisterer, K	1
Aigner, A; Boehm, A; Dietz, A; Mozet, C; Stoehr, M; Wichmann, G	1
Arai, Y; Isitoya, J; Komatsu, M; Nishimura, G; Oridate, N; Sakuma, N; Sakuma, Y; Sano, D; Shiono, O; Taguchi, T; Takahashi, M; Yabuki, K	1
Fujimoto, M; Fujisawa, Y; Kadono, T; Miyagawa, T; Nakamura, Y; Yoshino, K	1
Augereau, P; Breheret, R; Capitain, O; Laccourreye, L; Linot, B	1
Araki, K; Kamide, D; Shiotani, A; Tanaka, Y; Tomifuji, M; Yamashita, T	1
Argiris, A; Fu, P; Galanopoulos, N; Gibson, M; Lavertu, P; Machtay, M; Rezaee, R; Savvides, P; Wasman, J; Yao, M; Zender, C	1
Chen, CH; Lin, SF; Liu, YC; Sun, Y; Tang, JY; Wu, CF; Yang, WC	1
Akita, H; Fukuda, S; Hatakeyama, H; Homma, A; Kakizaki, T; Kano, S; Kinoshita, I; Mizumachi, T; Onimaru, R; Sakashita, T; Shimizu, Y; Shirato, H; Taguchi, J; Tsuchiya, K; Yasuda, K	1
Ang, K; Foote, RL; Gillison, ML; Harari, PM; Harris, J; Jordan, RC; Khuntia, D; Kies, MS; Machtay, M; Myers, JN; Rotman, M; Straube, W; Zhang, Q	1
Agulnik, MB; Braegas, B; Brockstein, BE; Cohen, EE; Egan, R; Haraf, DJ; Huang, CH; Karrison, TG; Kocherginsky, M; Kumar, P; Marchand, P; Mehra, R; Mittal, BB; Mueller, J; Ondrey, F; Raez, LE; Samant, S; Seiwert, TY; Villaflor, VM; Vokes, EE; Yunus, F	1
Hoshikawa, H; Indo, K; Kamitori, K; Mori, N; Mori, T; Tokuda, M; Yamaguchi, F	1
Aderhold, C; Birk, R; Faber, A; Hörmann, K; Schultz, JD; Sommer, JU; Umbreit, C	1
Boku, N; Fuke, T; Hamauchi, S; Haraguchi, Y; Hikosaka, T; Iida, Y; Izawa, N; Kamijo, T; Machida, N; Nakagawa, M; Nishimura, T; Ogawa, H; Onitsuka, T; Onozawa, Y; Todaka, A; Tsushima, T; Yasui, H; Yokota, T	1
Chung, CH; Fertig, EJ; Gillison, ML; Harari, PM; Harris, J; Jordan, RC; Kong, CS; Le, QT; Raben, D; Redmond, KP; Shenouda, G; Trotti, A; Wang, D; Zhang, Q	1
Carlson, SG; Chen, Z; Eytan, DF; Schiltz, S; Snow, GE; Van Waes, C	1
Agüero, A; Farré, N; García, J; León, X; López, M; López-Pousa, A; Quer, M	1
Hanai, N; Hasegawa, Y; Hirakawa, H; Nakashima, T; Nishikawa, D; Ozawa, T; Suzuki, H	1
Adkins, D; Bauman, JE; Beauregard, P; Bowles, DW; Hausman, D; Jimeno, A; Levy, B; Rudin, CM; Schnadig, I; Seetharamu, N; Shirai, K; Spira, A; Walker, L; Weissman, C	1
Adkins, DR; Diaz, J; Gay, H; Lewis, J; Ley, J; Michel, L; Nussenbaum, B; Paniello, RC; Rich, J; Schell, A; Thorstad, W; Trinkaus, K; Wildes, TM; Wu, N	1
Autret, D; Capitain, O; Cellier, P; El Alouani, C; Gustin, P; Jadaud, É; Laccourreye, L; Peyraga, G; Pointreau, Y; Septans, AL; Tuchais, C; Vinchon-Petit, S; Yossi, S	1
Cho, H; Hanamoto, A; Inohara, H; Nakahara, S; Nishiike, S; Takenaka, Y; Yamamoto, Y; Yasui, T	1
Fukuda, S; Furusawa, J; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Nakamaru, Y; Onimaru, R; Sakashita, T; Shirato, H; Terasaka, S; Tsuchiya, K; Yasuda, K; Yoshida, D	1
Inohara, H; Isohashi, F; Nakahara, S; Ogawa, K; Seo, Y; Sumida, I; Suzuki, O; Takenaka, Y; Tomiyama, Y; Yamamoto, Y; Yoshii, T; Yoshioka, Y	1
Bacchus, ID; Mittal, BB; Refaat, T; Sachdev, S; Sathiaseelan, V	1
Chen, CH; Chien, CY; Chiu, TJ; Chuang, HC; Fang, FM; Hsu, CM; Huang, TL; Huang, WT; Lai, CC; Li, SH; Lin, WC; Luo, SD; Su, YY	1
Breheret, R; Capitain, O; Laccourreye, L; Linot, B; Peyraga, G; Yossi, S	1
Das, D; Govindan, SV; Hicks, W; Kulsum, S; Kuriakose, MA; Pandian, RS; Seshadri, M; Suresh, A	1
Endo, Y; Koike, Y; Kuwatsuka, Y; Miyachi, Y; Okada, K; Utani, A	1
Kulkarni, AB; Liu, B; Sun, ZJ; Wang, YF; Zhang, L; Zhang, W; Zhang, WF; Zhao, YF	1
Carp, L; Corthouts, B; Specenier, P; Szturz, P; Van Den Weyngaert, D; Van Laer, C; Van Marck, E; Vanderveken, O; Vermorken, JB	1
Choi, SH; Kim, JH; Kim, SC; Ryoo, I; Sohn, CH	1
Bourhis, J; Bozec Le Moal, L; Dillies, AF; Fayette, J; Guigay, J; Henry, S; Kerger, JN; Machiels, JP; Pointreau, Y; Schilf, A; Sire, C; Tennevet, I; Zanetta, S	1
Feifan, Z; Kun, M; Lin, M; Xinxin, Z	1
Berg, S; Boessert, P; Fruth, K; Haxel, BR; Mann, WJ	1
Ahn, SH; Baek, SK; Hah, JH; Heo, DS; Hong, SH; Jung, KY; Kang, JH; Keam, B; Kim, DW; Kim, IA; Kim, KH; Kim, SB; Kim, SY; Kim, TM; Koh, Y; Kwon, TK; Lee, KW; Lee, SH; Lee, SW; Nam, SY; Shin, SW; Sung, MW; Wu, HG; Yoon, DH	1
Hanamoto, A; Honma, K; Inohara, H; Kitamura, K; Morii, E; Nakahara, S; Takenaka, Y; Yamamoto, Y; Yasui, T	1
Chen, NX; Yan, F; Zhang, XX; Zhao, FF	1
Egle, A; Gaggl, A; Greil, R; Hufnagl, C; Hutarew, G; Magnes, T; Melchardt, T; Moser, G; Neureiter, D; Schlattau, A; Tränkenschuh, W; Weiss, L	1
Iwabuchi, H; Komatsu, S; Nakayama, S; Onizawa, K; Souma, T; Uchiyama, K; Yamada, M; Yasui, T	1
Airoldi, M; Di Muzio, J; Fasolis, M; Franco, P; Garzaro, M; Garzino Demo, P; Melano, M; Moretto, F; Pecorari, G; Potenza, I; Ragona, R; Rampino, M; Ricardi, U; Riva, G; Schena, M	1
Bu, LL; Huang, CF; Liu, B; Liu, JF; Ma, SR; Sun, ZJ; Zhang, WF; Zhao, ZL	1
Bölke, E; Budach, W; Gerber, PA; Gripp, S; Kammers, K; Matuschek, C; Orth, K	1
de Boer, JP; de Jong, MA; Driessen, CM; Gelderblom, H; Kaanders, JH; Melchers, WJ; Rasch, CR; Tesselaar, ME; van der Graaf, WT; van Herpen, CM; Verbist, BM	1
Casanova, M; Errihani, H; Ferrari, A; Grzegorzewski, KJ; Orbach, D; Özyar, E; Pan, J; Patte, C; Shen, L; Varan, A; Veyrat-Follet, C; Zhang, L	1
Carles, J; Cruz, JJ; del Barco, E; Escobar, Y; García, C; García-Paredes, B; García-Sáenz, JA; Grau, JJ; Irigoyen, A; Lozano, A; Mañós, M; Mesía, R; Taberna, M; Vázquez, S	1
Alfonsi, M; Calais, G; Chapet, S; Garaud, P; Jadaud, E; Janoray, G; Pointreau, Y; Sire, C	1
Cho, BC; Choi, EC; Kim, HR; Kim, JH; Koh, YW; Lee, CG	1
Fu, P; Gibson, M; Lavertu, P; Machtay, M; Rezaee, R; Savvides, P; Sharma, N; Wasman, J; Woods, C; Yao, M; Zender, C	1
Calderon, B; Cowen, D; Dupuis, C; Fakhry, N; Guerder, C; Resbeut, M	1
Hah, JH; Han, DH; Heo, DS; Keam, B; Kim, DW; Kim, DY; Kim, TM; Kwon, TK; Lee, SH; Ock, CY; Rhee, CS; Sung, MW; Won, TB; Wu, HG	1
Kawada, K; Kawano, T; Miyawaki, Y; Nakajima, Y; Okada, T; Tokairin, Y	1
Chen, YH; Chien, CY; Chiu, TJ; Fang, FM; Hsu, CM; Huang, TL; Lai, CC; Li, SH; Lin, WC; Luo, SD; Su, YY	1
Azami, Y; Fuwa, N; Hareyama, M; Hatayama, Y; Hayashi, Y; Kikuchi, Y; Mitsudo, K; Nakamura, T; Ono, T; Suzuki, M; Takayama, K; Tohnai, I; Tsukiyama, I; Yamaguchi, H	1
Bu, LL; Gutkind, JS; Huang, CF; Kulkarni, AB; Liu, B; Liu, JF; Ma, SR; Sun, ZJ; Yu, GT; Zhang, L; Zhang, WF; Zhao, ZL	1
Ambrun, A; Céruse, P; Daveau, C; Diallo, A; Fayette, J; Fontaine-Delaruelle, C; Neidhardt, EM; Péron, J; Poupart, M; Ramade, A; Zrounba, P	1
Arai, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K	1
Ameri, A; Khoshbakht Ahmadi, H; Mortazavi, N; Novin, K	1
Bellile, E; Bradford, C; Carey, TE; Chepeha, DB; Eisbruch, A; Jackson, TL; Malloy, K; McKean, E; McLean, S; Moyer, J; Nör, JE; Pearson, AT; Prince, M; Sacco, AG; Shuman, A; Spector, ME; Sukari, A; Swiecicki, PL; Taylor, JM; Wang, S; Wolf, GT; Worden, FP	1
Chikamatsu, K; Ida, S; Mito, I; Sakakura, K; Takahashi, H	1
Chen, CC; Chen, CY; Chen, WM; Chen, YY; Chou, WC; Lee, KD; Lu, CH; Wang, TY; Yang, LY	1
Gill, HS; Mody, MD; Saba, NF	1
Ahn, PH; Anne, PR; Axelrod, RS; Cognetti, D; Dicker, AP; Keane, WM; Machtay, M; Wuthrick, E	1
Deák, P; Fábián, G; Kahán, Z; Kovács, L; Mózes, P; Nagy, O; Pál, M; Reisz, Z; Rovó, L; Rusz, O; Szilágyi, É; Tiszlavicz, L; Tomisa, B; Varga, Z	1
Arya, S; Goswami, C; Goud, S; Joshi, A; Juvekar, S; Murthy, V; Noronha, V; Patil, S; Patil, VM; Prabhash, K	1
Aretin, MB; Fuchs, H; Fuereder, T; Grah, A; Kornek, G; Pammer, J; Posch, D	1
Adkins, D; Axelrod, R; Dakhil, S; Debruyne, PR; Dong, J; Kornek, G; Murugappan, S; O'Brien, P; Oliner, KS; Pant, S; Wirth, LJ	1
Dumollard, JM; Forest, F; Fournel, P; Froudarakis, M; Gavid, M; Giroult, JB; Karpathiou, G; Monaya, A; Peoc'h, M; Prades, JM	1
Dosaka-Akita, H; Honma, R; Iseki, K; Kasashi, K; Kinoshita, I; Kobayashi, M; Saito, Y; Shimizu, Y; Takeuchi, S; Yamada, T	1
Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L	1
Chang, CL; Chen, JH; Chen, TM; Lai, MT; Lee, FP; Lin, KC; Wu, CC; Wu, SY; Yen, YC; Yuan, KS	1
Adkins, D; Daly, K; Ley, J; Oppelt, P; Wildes, TM	1
Furue, M; Uchi, H; Wada, N	1
Baghi, M; Gstoettner, W; Hambek, M; Knecht, R; Moertel, S; Strebhardt, K; Wagenblast, J	1
Bernier, J; Vrieling, C	1
Onizawa, K; Otsuka, Y; Yamagata, K; Yoshida, H	1
Enomoto, T; Fukutsuji, K; Ikeda, H; Kitano, H; Morizane, R; Nakahara, K; Nosaka, A; Sakoda, T; Shibano, A; Yamanishi, M	1
Castro, J; Friesland, S; Ghaderi, M; Laytragoon-Lewin, N; Lewin, F; Lundgren, J; Turesson, I; Ustun, H	1
Chitapanarux, I; Kamnerdsupaphon, P; Lorvidhaya, V; Sukthomya, V; Sumitsawan, Y; Tharavichitkul, E	1
Guntinas-Lichius, O; Klussmann, JP; Rühlow, S; Veelken, F	1
Burris, HA; Greco, FA; Hainsworth, JD; Kuzur, M; Lunin, S; Markus, TM; Shipley, D; Spigel, DR	1
Athanassiou, E; Bamias, A; Bobos, M; Fountzilas, G; Kalogera-Fountzila, A; Kalogeras, KT; Karayannopoulou, G; Kosmidis, P; Misailidou, D; Papakostas, P; Tolis, C; Tsekeris, P; Vamvouka, C; Zamboglou, N; Zaramboukas, T	1
Shinden, S; Shiotani, A; Watabe, T; Yamashita, T	1
Cho, BC; Choi, EC; Choi, HJ; Keum, KC; Kim, JH; Kim, SH; Lee, YJ; Shin, SJ	1
Choudhury, A; Clark, JI; Eisner, RM; Emami, B; Hofmeister, C; Lathers, D; Lau, A; Norton, J; Petruzzelli, G; Thomas, S; Young, MR	1
Boehm, A; Dietz, A; Dollner, R; Horn, IS; Mozet, C; Tschop, K; Wichmann, G	2
Hah, JH; Heo, DS; Jeon, YK; Kim, CW; Kim, DW; Kim, KH; Kim, TM; Koh, Y; Kwon, TK; Lee, SH; Rhee, CS; Sung, MW; Wu, HG	1
Adelstein, DJ; Giri, PG; Hanna, E; Mills, GM; Moon, J; Urba, SG; Wolf, GT	1
Corry, P; Moros, EG; Peñagarícano, JA; Ratanatharathorn, V; Yan, Y	1
Argiris, A; Axelrod, R; Brockstein, B; Buchanan, A; Forastiere, A; Ghebremichael, M; Hahn, K; Kolesar, J; Pins, M	1
Caponigro, F; Ionna, F; Longo, F; Perri, F	1
Hanai, N; Hasegawa, Y; Hirakawa, H; Ozawa, T; Terada, A; Yokoi, H	1
Andreozzi, B; Annino, D; Balboni, TA; Costello, R; Goguen, L; Haddad, RI; Lorch, J; Norris, C; Posner, MR; Tishler, RB; Wirth, L	1
Fukuda, S; Hatakeyama, S; Kano, S; Maeda, H; Miyajima, N; Okumura, F; Tsukiyama, T	1
Beltran, P; Brammer, C; Jansen, JP; Parthan, A; Posner, MR	1
Buiret, G; Céruse, P; Combe, C; Ecochard, R; Favrel, V; Fayette, J; Martin, L; Pommier, P; Ramade, A; Tartas, S	1
Aulino, J; Baumann, J; Burkey, B; Chung, CH; Cmelak, AJ; Gilbert, J; Hatakeyama, H; Muldowney, NJ; Murphy, BA; Netterville, J; Parker, J; Shyr, Y; Sinard, R; Slebos, RJ; Yarbrough, WG	1
Ju, JH; Kang, JH; Kang, MH; Kim, HG; Kim, JP; Lee, GW; Park, JJ	1
Cullen, KJ; Goloubeva, O; Haddad, RI; Nikitakis, N; Posner, MR; Sarlis, NJ; Schumaker, L; Tan, M	1
Budach, V; Keilholz, U; Klinghammer, K; Knödler, M; Schmittel, A; Tinhofer, I	1
Ardizzoia, A; Bonetti, A; Buffoli, A; Campostrini, F; Cavallo, R; Dondi, D; Gardani, G; Gava, A; Ghi, MG; Guaraldi, M; Koussis, H; Loreggian, L; Mione, CA; Paccagnella, A; Tomio, L	1
Altintas, S; Dyck, J; Huizing, MT; Schrijvers, D; Specenier, PM; Van Den Brande, J; Van Den Weyngaert, D; Van Laer, C; Vermorken, JB	1
Birnbaum, A; DiPetrillo, T; Kennedy, T; Rathore, B; Rathore, R; Ready, N	1
Arnoldner, C; Bisdas, S; Gstöttner, W; Hambek, M; May, A; Mörtel, S; Wagenblast, J	1
Chays, A; Maillard, S; Merol, JC; Nguyen, TD	1
Kimura, T; Kogashiwa, Y; Kohno, N; Sakurai, H	1
Adachi, M; Furuse, S; Ijichi, K; Mitsudo, K; Miura, S; Nakazawa, M; Ohta, S; Tohnai, I; Torigoe, S	1
Bamberg, M; Belka, C; Berger, B; Budach, W; Hehr, T; Weinmann, M	1
Bruzzone, A; Dellepiane, M; Figliomeni, M; Ghio, R; Grillo-Ruggieri, F; Grimaldi, A; Mencoboni, M; Moratti, G; Rebella, L; Salami, A; Scasso, F; Spigno, F	1
Agrawal, A; Aimiumu, J; Chan, KK; Chen, P; Cheng, H; Dancey, J; Grever, MR; Kraut, EH; Lang, J; Rhoades, C; Young, DC; Zhang, Y	1
Ensley, JF; Folbe, AJ; Kafri, Z; Kim, H; Lin, HS; Lonardo, F; Stevens, T; Won, J; Yoo, GH	1
Araki, K; Doi, T; Fuse, N; Hayashi, R; Kawashima, M; Kiyota, N; Minami, H; Minashi, K; Ogino, T; Ohtsu, A; Okano, S; Tahara, M; Yoshino, T; Zenda, S	1
Foster, J; Lee, J; Urba, S; Worden, F; Zhang, J	1
Chitapanarux, I; Lorvidhaya, V; Mayurasakorn, S; Pattarasakulchai, T; Sittitrai, P; Srivanitchapoom, C; Tananuwat, R; Tharavichitkul, E	1
Fujimoto, Y; Furue, H; Fuwa, N; Itoh, Y; Mitsudo, K; Nishiguchi, H; Shigetomi, T; Tohnai, I; Ueda, M; Yamamoto, N	1
Taniguchi, M; Toyama, T; Tsujizakae, H; Watanabe, A	1
Yoshida, T	1
Furuta, J; Hori, E; Kawachi, Y; Nakamura, Y; Otsuka, F	1
Bernier, J; Betka, J; Bottomley, A; Coens, C; Degardin, M; Jelic, S; Mauer, ME; Mesia, R; Preiss, JH; Remenar, E; Stewart, JS; van den Weyngaert, D; van Herpen, CM; Vermorken, JB	1
Anders, C; Bran, G; Faber, A; Hörmann, K; Sadick, H; Sauter, A; Schultz, JD	1
Dyck, J; Huizing, MT; Rasschaert, M; Schrijvers, D; Specenier, P; Van den Brande, J; Vermorken, JB; Vroman, P	1
Vokes, EE	1
Budach, V	1
D'Amanzo, P; Ghi, MG; Mastromauro, C; Paccagnella, A	1
Calais, G	2
Argiris, A; Branstetter, BF; Dacic, S; Ferris, RL; Gibson, MK; Gooding, W; Grandis, JR; Heron, DE; Johnson, JT; Kim, S; Lai, SY; Posluszny, DM; Seethala, RR; Smith, RP; Wang, L	1
Egawa, S; Furuta, A; Ikeda, K; Kamakazu, K; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H	1
Chang, SY; Chang, YC; Chu, PY; Hsieh, SL; Li, WY; Tai, SK; Tsai, TL; Wang, YF; Yang, MH	1
Carron, MA; Kucuk, O; Lin, HS; Shkoukani, MA; Tulunay, O	1
Cullen, K; Fasciano, J; Goloubeva, O; Haddad, RI; Lorch, JH; Posner, MR; Sammartino, DE; Sarlis, N; Tan, M; Tishler, R	1
Chilimoniuk, M; Maksimowicz, T; Olszewska, E	1
Devlin, PM; Haddad, RI; Holupka, EJ; Posner, MR; Sarlis, NJ; Sher, DJ; Tishler, RB	1
Arango, BA; Burgos-Tiburcio, A; Raez, LE; Santos, ES	1
Chang, PM; Chang, SY; Chang, YF; Chen, MH; Hwang, WS; Su, WC; Tsao, CJ; Tzeng, CH; Yang, MH	1
Anglada, L; Arellano, A; Barnadas, A; de Vega, JM; Galiana, R; Lloansí, A; López-Pousa, A; Majem, M; Margelí, M; Mesía, R; Valentí, V	1
Devisetty, K; Mell, LK; Wong, SJ	1
Atean, I; Calais, G; Pointreau, Y	1
Dai, Y; Fan, CY; Neis, JP; Spring, PM; Vural, E; Xie, CH	1
Fujiki, Y; Hama, T; Hatake, K; Ishibashi, M; Kawakami, K; Kawata, K; Mishima, Y; Nemoto, M; Sugisaki, T; Takahashi, S; Yokoyama, M	1
Itou, S; Kanazawa, J; Namba, R; Nawa, T; Yamamoto, Y	1
Coyle, C; Dyker, K; Öksüz, DÇ; Prestwich, RJ; Şen, M	1
Budach, V; Gauler, T; Keilholz, U; Klinghammer, K; Knödler, M; Stenzinger, A; Tinhofer, I; Weichert, W	1
Bernier, J	1
Bozec, A; Brunstein, MC; Etienne-Grimaldi, MC; Fischel, JL; Milano, G; Sudaka, A	1
Benezery, K; Dassonville, O; Hebert, C; Peyrade, F; Saâda, E	1
Argiris, A; Branstetter, BF; Feinstein, T; Ferris, RL; Gooding, W; Grandis, JR; Lee, SC; Seethala, R; Thomas, S; Wang, L	1
Blumenschein, GR; Charnsangavej, C; Fossella, FV; Fujimoto, J; Hong, WK; Kies, MS; Lee, JJ; Liu, S; Marom, EM; Papadimitrakopoulou, V; Stewart, DJ; Tran, HT; Tsao, AS; Wistuba, II	1
Bergmann, ZP; Debus, J; Freier, K; Jensen, AD; Krauss, J; Münter, MW; Weichert, W	1
Chan, CH; Chen, CC; Chen, PT; Chen, WC; Huang, CE; Kuan, FC; Lee, KD; Lu, CH; Wang, WH; Wu, JY	1
Chen, RC; Copp, JA; Cox, AD; Cummings, ND; Karve, S; Li, C; Napier, ME; Sukumar, R; Wang, AZ; Werner, ME	1
Correa, PD; Grose, D; Paterson, C; Rizwanullah, M; Robertson, AG	1
Gorlia, T; Liberato, NL; Licitra, L; Marchetti, M; Quaglini, S; Rognoni, C; Rubrichi, S; Vermorken, JB	1
Dong, Z; Imai, A; Krishnamurthy, S; Light, E; Nör, JE; Visioli, F; Wang, S; Worden, F; Zeitlin, BD; Zhang, Z	1
Bi, CP; Chang, TH; Chen, MK; Lai, GM; Lin, JT; Liu, MT; Wang, JW	1
Fuwa, N; Inokuchi, H; Makita, C; Nakamura, T; Shiomi, M; Takada, A; Takayama, K; Tomoda, T; Watanabe, K; Yokouchi, J	1
Demidov, LV; Kanagavel, D; Orlova, KV; Petenko, NN; Samoĭlenko, IV; Subramanian, S	1
Fujikawa, A; Furugen, A; Iseki, K; Ito, H; Kobayashi, M; Mano, N; Miyamori, K; Ogura, J; Takahashi, N; Tanaka, N; Yamada, T; Yamaguchi, H	1
Knecht, R; Laban, S; Mumme, AM	1
Abbruzzese, A; Caraglia, M; Giordano, A; Giuberti, G; Grimaldi, A; Lombardi, A; Misso, G; Ricciardiello, F; Tagliaferri, P	1
Bukawa, H; Fujisawa, Y; Karube, R; Onizawa, K; Otsuka, F; Sasaki, H; Shinozuka, K; Yamagata, K; Yanagawa, T	1
Coyle, C; Dyker, KE; Karakaya, E; Oksuz, DC; Prestwich, RJ; Sen, M; Yetmen, O	1
Abgral, R; Gouders, D; Keromnes, N; Le Roux, PY; Leleu, C; Mollon, D; Nowak, E; Querellou, S; Rousset, J; Salaün, PY; Valette, G	1
Anderhuber, W; Bachtiary, B; Berghold, A; Burian, M; De Vries, A; Elsäßer, W; Greil, R; Kainz, H; Kapp, KS; Kasparek, AK; Keil, F; Kopp, M; Kornek, G; Reinisch, S; Riedl, R; Selzer, E; Tinchon, C	1
Furuya, T; Hirowatari, H; Ito, K; Ito, S; Izawa, H; Karasawa, K; Matsumoto, F; Oba, S; Sasai, K	1
Asakawa, T; Furusaka, T; Ikeda, M; Matsuda, H; Tanaka, A	1
Baek, SK; Jung, KY; Kim, CY; Kim, DS; Kim, IS; Kim, JS; Kim, YH; Kwon, SY; Lee, NJ; Park, KH; Park, Y; Shin, SW	1
Iwabuchi, H; Nakayama, S; Sugiyama, K; Uchiyama, K; Yamada, M	1
Caudell, JJ; Hamilton, RD; Jennelle, RL; Otto, KJ; Pitman, KT; Vijayakumar, S	1
Durdux, C; Huguet, F; Lang, P; Monnier, L; St Guily, JL; Touboul, E	1
Glisson, BS	1
Hong, WK	1
Baur, M; DeSantis, M; Dittrich, C; Gerber, E; Hudec, M; Kienzer, HR; Pont, J; Schratter-Sehn, AU; Schweiger, J; Wicke, W	1
Abad, A; Barnadas, A; Font, A; Guillot, M; Manzano, JL; Margeli, M; Martinez, E; Rosell, R; Sanchez, JM; Taron, M	1
Bourhis, J; Faivre, S; Monnerat, C; Raymond, E; Temam, S	1
Busse, PM; Case, M; Colevas, AD; Costello, R; Frankenthaler, R; Karp, D; Lake-Willcutt, B; Lamb, CC; Nixon, A; Norris, CM; Posner, MR; Tishler, RB	1
Burian, M; Cartellieri, M; Fiebiger, W; Formanek, M; Gedlicka, C; Kornek, GV; Kornfehl, J; Marks, B; Selzer, E	1
Ensley, JF; Kewson, D; Lonardo, F; Meng, H; Nguyen, T; Oliver, J; Piechocki, MP; Shibuya, TY; Tainsky, MA; Yoo, GH	1
Busse, P; Case, MA; Colevas, AD; Costello, R; Goguen, L; Haddad, R; Lake-Willcutt, B; Norris, CM; Posner, M; Sullivan, C; Tishler, R	1
Lefebvre, JL; Posner, MR	1
Odagiri, K; Okami, K; Onuki, J; Sakai, A; Takahashi, M	1
Busse, P; Case, MA; Costello, R; Goguen, LA; Haddad, R; Mahadevan, A; Norris, CM; Posner, MR; Sullivan, CA; Tishler, RB; Wirth, L	1
Haddad, RI; Van Echo, DA	1
Airoldi, M; Beatrice, F; Bumma, C; Cattel, L; Marchionatti, S; Maria Gabriele, A; Pedani, F; Recalenda, V; Succo, G; Tagini, V	1
Kanamori, S; Kawamoto, M; Koike, R; Mori, K; Nakamatsu, K; Nishimura, Y; Suzuki, M	1
Liu, WW; Yu, QW; Zeng, J; Zeng, ZY	1
Gooding, WE; Grandis, JR; Li, M; Lui, VW; Niwa, H; Wentzel, AL	1
Sasaki, S; Taniguchi, M; Watanabe, A	1
Kawamoto, K; Kuroiwa, T; Ochiai, N; Tajima, T; Tomita, K; Yabuuchi, H	1
Nabell, L; Spencer, S	1
Ahmed, MM; Arnold, SM; Brown, B; Dey, S; Jones, R; Lele, SM; Mohiuddin, M; Shajahan, S; Spring, PM; Valentino, J	1
Awada, A; Castelijns, JA; De Mulder, P; Joosens, E; Kaanders, J; Kerger, J; Le Bouder, C; Nguyen, H; Schrijvers, D; Van den Weyngaert, D; Van Herpen, C; Van Laer, C; Vermorken, JB	1
Bourhis, J; Dalley, DN; Domenge, C; Dunant, A; Le Lann, L; Lewin, F; Mazumdar, M; Olivares, R; Paccagnella, A; Pignon, JP; Posner, M; Syz, N; Taylor, SG; Yver, A	1
Airoldi, M; Bumma, C; Cattel, L; Cortesina, G; Danova, M; Gabriele, AM; Giordano, C; Pedani, F; Porta, C; Recalenda, V; Tagini, V	1
Fujii, M; Inuyama, Y; Kida, A; Kohno, N; Kubota, A; Okami, K; Satake, B; Tsukuda, M	1
Biason, R; Carnuccio, R; D'Amanzo, P; Fasan, S; Fila, G; Gatti, C; Ghi, MG; Mastromauro, C; Medici, M; Mione, CA; Nascimben, O; Oniga, F; Paccagnella, A; Pallini, A; Paro, S; Rossi, F; Turcato, G	1
Ayers, D; Chi, KN; Chia, S; Cripps, C; Fry, D; Gelmon, KA; Huan, S; Janke, S; McIntosh, L; Seymour, LK; Shabbits, JA; Stewart, D; Walsh, W	1
Blay, JY; Bleuze, JP; Bompas, E; Chaigneau, L; Cupissol, D; Guardiola, E; Madroszyk, A; Peyrade, F; Pivot, X; Ronchin, P; Schneider, M; Tchiknavorian, X	1
Ensley, JF; Kim, H; Lin, HS; Lonardo, F; Oliver, J; Piechocki, MP; Shehadeh, N; Shibuya, TY; Yoo, GH; Zumstein, L	1
Bendahmane, B; Bontemps, P; Bourgeois, H; Calais, G; Cupissol, D; Dutin, JP; Genet, D; Mallard-Carre, M; Philippi, MH; Tubiana-Mathieu, N	1
Bitter, K; Böttcher, HD; Kovács, AF; Mose, S	1
Hennequin, C	1
Hirose, S; Horiuchi, C; Ikeda, Y; Ishitoya, J; Katori, H; Kimura, M; Matsuda, H; Mikami, Y; Sakuma, Y; Sato, N; Taguchi, T; Takahashi, M; Tanigaki, Y; Tsukuda, M; Yamamoto, K; Yoshida, T	1
Bamberg, M; Belka, C; Budach, W; Classen, J; Hehr, T; Koitschev, A; Schäfer, J; Welz, S	1
Schrijvers, D; Vermorken, JB	3
Hatta, N; Mizuno, M; Oishi, N; Takehara, K; Yamada, M	1
Anderson, L; Anzai, Y; Boyd, C; Buelna, R; Canby, R; Donahue, M; Hutson, J; Keegan, K; Montgomery, RB; Schwartz, DL; Yueh, B	1
Boinpally, RR; Ensley, JF; Ezzat, W; Iskander, A; Lin, HS; Oliver, J; Parchment, RE; Piechocki, MP; Polin, L; Shehadeh, N; Shibuya, TY; Subramanian, G; Yoo, GH	1
Berrocal, A; Cruz, JJ; Fonseca, E; García-Gómez, JM; Grau, JJ; Lara, MA; Navalón, M; Pastor, M; Rueda, A; Sastre, J; Tisaire, JL	1
Chin, K; Hatake, K; Inamura, K; Ito, Y; Kobayashi, T; Mishima, Y; Mizunuma, N; Nagasaki, E; Nishimori, H; Shinozaki, E; Takahashi, S; Terui, Y; Yokoyama, M	1
Argiris, A; Jayaram, P; Pichardo, D	1
Ando, A; Hasegawa, Y; Hyodo, I; Ogawa, T; Ozawa, T; Suzuki, Y; Terada, A	1
Akimoto, T; Chikamatsu, K; Furuya, N; Ishikawa, H; Katoh, H; Kitamoto, Y; Nakano, T; Ninomiya, H; Nonaka, T	1
Fukuda, T; Hosoi, H; Okamoto, H; Yamanaka, T; Yane, K	1
Ensley, JF; Iskander, AJ; Kewson, D; Kim, H; Kim, HR; Lin, HS; Lonardo, F; Oliver, J; Piechocki, MP; Tainsky, MA; Yoo, GH	1
Amador, ML; Cortes-Funes, H; del Val, O; Hernando, S; Hitt, R; Jimeno, A; Quintela-Fandino, M	1
Gajewski, BJ; Mayo, MS	1
Tohnai, I	1
Fujii, M	1
Kohno, N	1
Appenrodt, S; Guntinas-Lichius, O; Krug, B; Veelken, F	1
Busse, PM; Case, M; Costello, R; Goguen, L; Haddad, RI; Mahadevan, A; Norris, CM; Posner, MR; Sammartino, D; Stowell, S; Sullivan, C; Tishler, RB; Wirth, LJ	1
Douzinas, EE; Giannakouras, G; Ioannidou, G; Katsilieris, I; Kritselis, G; Liossi, P; Rapidis, AD; Roupakia, A; Stavrinidis, E; Trichas, M	1
Goguen, L; Haddad, R; Li, Y; Norris, CM; O'Donnell, L; Posner, M; Sullivan, C; Tishler, R; Wirth, L	1
Funato, N; Hiramatsu, H; Ito, H; Shimizu, A; Tokashiki, R; Tsukahara, K; Yoshida, T	1
Ang, KK; Clayman, GL; Feng, L; Garden, AS; Glisson, BS; Khuri, F; Kies, MS; Lee, JJ; Lewin, J; Morrison, W; Myers, J; Papadimitrakopoulou, V; Tsao, AS; Zinner, R	1
Furusaka, T	1
Hiroi, S; Masumoto, K; Nozawa, H; Ono, T; Sato, M; Sato, Y; Tadakuma, T	1
Boswell, JS; Flam, MS; Tashjian, DN; Tschang, TP	1
Baghi, M; Bisdas, S; Gstoettner, W; Hambek, M; Knecht, R; Mack, MG; Muerthel, R; Vogl, T; Wagenblast, J	1
Doto, R; Furusawa, K; Li, X; Matsuura, T; Naramoto, H; Takahashi, M; Uchihashi, T; Uematsu, S; Uematsu, T; Usui, Y; Yamaoka, M	1
Iwabuchi, H; Nakayama, S; Uchiyama, K	1
Burkey, BB; Chen, C; Cmelak, AJ; Kane, MA; Kish, B; Murphy, BA; Netterville, JL; Raben, D; Shakhtour, B; Shyr, Y; Song, JI; Willey, CD	1
Biete Solà, A; Calvo Manuel, FA; de Las Heras González, M; Grau de Castro, JJ; Marruecos Querol, J; Palacios Eito, A; Ramos Aguerri, A; Rovirosa Casino, A; Solano López, MV; Veiras Candal, C; Verger Fransoy, E	1
Chen, Z; Choe, MS; Klass, CM; Shin, DM; Zhang, X	1
Baghi, M; Gstöttner, W; Hambek, M; Knecht, R; Werner, C	1
Borel, C; Calais, G; Cupissol, D; Eymard, JC; Germann, N; Kohser, F; Labourey, JL; Tourani, JM; Tubiana-Mathieu, N	1
Atago, Y; Fukuda, S; Furuta, Y; Higuchi, E; Homma, A; Nagahashi, T; Oridate, N; Suzuki, F	1
Homma, A	1
Ackermann, H; Baghi, M; Gstöttner, W; Hambek, M; Knecht, R; Strebhardt, K; Wagenblast, J	1
Boku, N; Ebihara, M; Iida, Y; Onitsuka, T; Onozawa, Y; Zenda, S	1
Blair, EA; Cohen, EE; Dekker, A; Haraf, DJ; Mauer, A; Seiwert, TY; Stenson, K; Vokes, EE	1
Cho, GJ; Choi, YJ; Chung, JS; Kim, DW; Lee, BJ; Shin, HJ; Wang, SG	1
Kies, MS	1
Awada, A; Bernier, J; Betka, J; Cupissol, D; Degardin, M; Desaunois, I; Gorlia, T; Jelic, S; Kienzer, HR; Lefebvre, JL; Mesia, R; Preiss, JH; Remenar, E; Rey, A; Stewart, JS; van den Weyngaert, D; van Herpen, C; Vermorken, JB	1
Agarwala, S; Blajman, CR; Cmelak, A; Cohen, RB; Colevas, AD; Cullen, K; Dugan, M; Ervin, TJ; Gorbounova, V; Haddad, RI; Harter, KW; Hershock, DM; Markoe, AM; Mickiewicz, E; Murphy, BA; Norris, CM; Posner, MR; Raez, LE; Read, PW; Romanov, I; Roth, B; Shin, DM; Spaulding, M; Steinbrenner, L; Tishler, RB; Tjulandin, S; Venkatesan, V; Viroglio, Rdel C; Winquist, E	1
Cho, EK; Kim, DY; Kim, ST; Lee, JH; Lee, KC; Lee, SH; Lee, Y; Park, J; Park, SH; Shin, DB	1
Freilino, ML; Gooding, WE; Grandis, JR; Ogagan, MJ; Strychor, S; Thomas, SM; Walsh, DR; Zamboni, WC	1
Fuwa, N; Kodaira, T; Nakamura, T	1
Argiris, A; Axelrod, R; Burtness, BA; Forastiere, AA; Manola, J	1
Kutner, A; Milczarek, M; Wietrzyk, J	1
Bölke, E; Gripp, S; Peiper, M	1
Ang, K; Forastiere, A; Weber, R	1
Bhide, SA; Harrington, KJ; Nutting, CM	1
Pajak, TF; Ridge, JA; Trotti, A	1
Bisegna, R; Bratta, M; Candeloro, G; Di Staso, M; Necozione, S; Rea, S; Recchia, F; Tombolini, V	1
Glisson, BS; Johnson, FM; Saigal, B	1
Fukuda, S; Furusawa, J; Furuta, Y; Hatakeyama, H; Higuchi, E; Homma, A; Mizumachi, T; Oridate, N; Suzuki, F; Taki, S	1
Aamdal, S; Catimel, G; Sternberg, C; Sulkes, A; van Hoesel, Q; Verweij, J; Wolff, I	1
Braakhuis, BJ; Kegel, A; Welters, MJ	1
Catimel, G; Clavel, M; Franklin, H; Hanauske, A; Kaye, SB; Le Bail, N; Mattijssen, V; Piccart, M; Verweij, J; Wanders, J	1
Busse, PM; Clark, JR; Costello, R; Dreyfuss, AI; Lucarini, JW; Norris, CM; Posner, MR; Poulin, MD; Rossi, RM; Thornhill, L	1
Verweij, J	1
Trudeau, ME	1
Devriendt, D; Klastersky, J	1
Fukuda, S; Inuyama, Y; Satoh, N	1
Valero, V	1
Burris, HA	1
Adak, S; Barton, JJ; Busse, PM; Colevas, AD; Costello, R; Dreyfuss, A; Fabian, RL; Fitzgerald, TJ; Fried, M; Norris, CM; Peters, ES; Posner, MR; Poulin, M; Tishler, RB	1
Colevas, AD; Posner, MR	1
Orel, NF	1
Baba, S; Ebihara, S; Horiuchi, M; Ichikawa, G; Inuyama, Y; Kamata, S; Kanzaki, J; Kataura, A; Kida, A; Konno, A; Kono, N; Kubota, A; Matsunaga, T; Matsuura, H; Miyake, H; Moriyama, H; Saijo, S; Saito, H; Sakai, M; Sasaki, Y; Satake, B; Taguchi, T; Takeoda, S; Togawa, K; Tsukuda, M	1
Catimel, G; Droz, JP; Gras, L; Hanauske, AR; Planting, AS; Schöffski, P; Schrijvers, A; Schrijvers, D; Verweij, J; Wanders, J	1
Khattab, J; Urba, SG	1
Armand, JP; Bordessoule, S; Chouaki, N; Couteau, C; De Forni, M; Domenge, C; Groult, V; Janot, F; Lebecq, A; Leyvraz, S; Oulid-Aissa, D	1
Choy, H	1
De Mulder, PH	1
Forastiere, AA	1
Achterrath, W; Feldmann, HJ; Heinrich, B; Hesse, K; Kau, R; Molls, M; Sommer, G; Zimmermann, F	1
Tsukuda, M	1
Boukis, H; Janinis, J; Lefantzis, D; Panagos, G; Papadakou, M; Poulis, A; Xidakis, E	1
Brockstein, B	1
Adak, S; Amrein, PC; Barton, JJ; Colevas, AD; Costello, R; Posner, MR	1
Fujii, H; Igarashi, T; Imoto, S; Ishizawa, K; Ito, K; Kubota, K; Minami, H; Saeki, T; Sasaki, Y; Takashima, S	1
Colevas, AD; Posner, MR; Tishler, RB	1
Glisson, BS; Hong, WK; Khuri, FR; Lippman, SM; Shin, DM	1
Hansen, HS; Larsen, SK; Specht, L	1
Al-Sarraf, M; Colevas, AD; Frenette, G; Garay, CA; Glisson, B; Norris, CM; Olivares, R; Posner, MR; Seroskie, JD; Shin, DM	1
Fumoleau, P; Schöffski, P; Verweij, J; Wanders, J	1
Boghun, O; Hess, CF; Lehmann, J; Lücke, E; Pradier, O; Rave-Fränk, M; Schmidberger, H	1
Avallone, A; Biglietto, M; Caponigro, F; Comella, G; Comella, P; De Lucia, L; Mantovani, G; Manzione, L; Massa, E; Rosati, G; Sganga, P; Sguotti, C	1
Posner, MR	1
Bittner, C; Feyerabend, T; Peters, SO; Raap, M; Remmert, S; Robins, IH; Sieg, P; Sommer, K; Wiedemann, GJ	1
Prescott, LM	1
Dokianakis, G; Georgoulias, V; Hatzidaki, D; Janinis, J; Lefantzis, D; Panagos, G; Panousaki, A; Papadakou, M	1
Airoldi, M; Bumma, C; Cattel, L; Delprino, L; Recalenda, V; Rocco, F; Tagini, V	1
Airoldi, M; Arpicco, S; Brusa, P; Bumma, C; Cattel, L; Recalenda, V; Tagini, V	1
Yokoyama, J	1
Merlano, M; Numico, G	1
Forastiere, AA; Frenette, G; Glisson, BS; Khuri, FR; Murphy, BA	1
Fuwa, N	1
Adak, S; Colevas, AD; Costello, R; Fried, MP; Goguen, LA; Gopal, HV; Lamb, CC; Norris, CM; Posner, MR; Read, R; Tishler, RB	1

Reviews

51 review(s) available for docetaxel anhydrous and Cancer of Head

Article	Year
Efficacy of first-line systemic treatment regimens for recurrent/metastatic head and neck squamous cell carcinoma: a network meta-analysis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023, Volume: 280, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Network Meta-Analysis; Squamous Cell Carcinoma of Head and Neck	2023
Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology. Medical oncology (Northwood, London, England), 2017, Volume: 34, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Feasibility Studies; Fluorouracil; Head and Neck Neoplasms; Humans; Retrospective Studies; Taxoids	2017
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma? Anti-cancer drugs, 2018, Volume: 29, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Survival Rate	2018
Induction chemotherapy in head and neck cancers: Results and controversies. Oral oncology, 2019, Volume: 95 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngectomy; Larynx; Neoplasm Staging; Organ Sparing Treatments; Progression-Free Survival; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck	2019
Unresectable Recurrent Squamous Cell Carcinoma of the Temporal Bone Treated by Induction Chemotherapy Followed by Concurrent Chemo-Reirradiation: A Case Report and Review of the Literature. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2015, Volume: 36, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Re-Irradiation; Skull Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids; Temporal Bone	2015
[A Case of Nasopharyngeal Cancer with Febrile Neutropenia Followed by Death during Adjuvant Chemotherapy]. Nihon Jibiinkoka Gakkai kaiho, 2015, Volume: 118, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Colitis; Docetaxel; Fatal Outcome; Febrile Neutropenia; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasopharyngeal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Staphylococcal Infections; Taxoids	2015
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 118, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Randomized Controlled Trials as Topic; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome	2016
The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review. JAMA otolaryngology-- head & neck surgery, 2016, 09-01, Volume: 142, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Immunotherapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Taxoids	2016
Docetaxel in the management of patients with head and neck squamous cell carcinoma. Expert review of anticancer therapy, 2008, Volume: 8, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Taxoids	2008
Docetaxel in the management of head and neck cancer. Anti-cancer drugs, 2009, Volume: 20, Issue:8 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Drug Therapy, Combination; ErbB Receptors; Head and Neck Neoplasms; Humans; Taxoids	2009
Induction chemotherapy for head and neck cancer: recent data. The oncologist, 2010, Volume: 15 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Radiation-Sensitizing Agents; Taxoids; Time Factors	2010
TPF sequential therapy: when and for whom? The oncologist, 2010, Volume: 15 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Taxoids	2010
TPF: a rational choice for larynx preservation? The oncologist, 2010, Volume: 15 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngectomy; Taxoids	2010
Development of targeted therapy for squamous cell carcinomas of the head and neck. Expert review of anticancer therapy, 2011, Volume: 11, Issue:3 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Insulin-Like Growth Factor I; Neoplasm Metastasis; NF-kappa B; Proteasome Inhibitors; Recurrence; Taxoids; Vascular Endothelial Growth Factor A	2011
[Induction chemotherapy for head and neck epidermoid carcinomas]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:6-7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Feasibility Studies; Fluorouracil; Head and Neck Neoplasms; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome	2011
[Use of docetaxel in treatment of squamous-cell carcinoma of head and neck]. Voprosy onkologii, 2011, Volume: 57, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Head and Neck Neoplasms; Humans; Molecular Targeted Therapy; Taxoids; Treatment Outcome	2011
New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012, Volume: 269, Issue:11 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Taxoids	2012
The role of docetaxel in the management of squamous cell cancer of the head and neck. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:6 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Radiation-Sensitizing Agents; Taxoids	2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Taxoids; Treatment Outcome	2002
End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Squamous Cell; Docetaxel; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Randomized Controlled Trials as Topic; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome	2002
Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. British journal of cancer, 2003, Jan-13, Volume: 88, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Neoplasm Staging; Paclitaxel; Remission Induction; Taxoids	2003
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. The oncologist, 2003, Volume: 8, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Taxoids	2003
Docetaxel with concurrent radiotherapy in head and neck cancer. Seminars in oncology, 2003, Volume: 30, Issue:6 Suppl 18 Topics: Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Radiation-Sensitizing Agents; Stomatitis; Taxoids	2003
[Docetaxel and squamous cell carcinoma of the head and neck]. Bulletin du cancer, 2004, Volume: 91, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Remission Induction; Taxoids	2004
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck. Anti-cancer drugs, 2004, Volume: 15, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Randomized Controlled Trials as Topic; Taxoids	2004
[Association of taxanes and radiotherapy: preclinical and clinical studies]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2004, Volume: 8 Suppl 1 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cells, Cultured; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoplasms; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy Dosage; Taxoids; Time Factors; Tumor Cells, Cultured	2004
Taxanes in the treatment of head and neck cancer. Current opinion in oncology, 2005, Volume: 17, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Head and Neck Neoplasms; Humans; Medical Oncology; Paclitaxel; Taxoids	2005
Revisiting induction chemotherapy for head and neck cancer. Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Paclitaxel; Taxoids	2005
[The role of taxanes for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Neutropenia; Taxoids	2005
Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN). Current treatment options in oncology, 2007, Volume: 8, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Remission Induction; Taxoids	2007
[Recent progress on radiotherapy for head and neck neoplasms]. Nihon Jibiinkoka Gakkai kaiho, 2007, Volume: 110, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Elementary Particles; Fluorouracil; Head and Neck Neoplasms; Humans; Radiosurgery; Radiotherapy; Radiotherapy, Intensity-Modulated; Taxoids	2007
Docetaxel: a review of its pharmacology and clinical activity. The Canadian journal of oncology, 1996, Volume: 6, Issue:1 Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Division; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Eruptions; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Microtubules; Neutropenia; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Taxoids; Tubulin	1996
New cytostatic agents for the treatment of head and neck cancer. Acta oto-rhino-laryngologica Belgica, 1997, Volume: 51, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids	1997
[Head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:13 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Taxoids	1997
Docetaxel in combination with fluorouracil for advanced solid tumors. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adult; Aged; Animals; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Models, Animal; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Mice; Middle Aged; Mucous Membrane; Neoplasms; Neutropenia; Paclitaxel; Taxoids	1997
Update on the taxoids and other new agents in head and neck cancer therapy. Current opinion in oncology, 1998, Volume: 10, Issue:3 Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; DNA Replication; DNA, Neoplasm; Docetaxel; Drug Administration Schedule; Enzyme Inhibitors; Head and Neck Neoplasms; Humans; Interferon-alpha; Microtubules; Neoplasm Proteins; Organoplatinum Compounds; Paclitaxel; Radiation-Sensitizing Agents; Remission Induction; Taxoids; Topoisomerase II Inhibitors; Treatment Outcome; Tubulin Modulators	1998
Docetaxel in head and neck cancer: a review. American journal of clinical oncology, 1998, Volume: 21, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation-Sensitizing Agents; Taxoids	1998
[Taxotere in various solid tumors]. Voprosy onkologii, 1998, Volume: 44, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	1998
Chemotherapy in head and neck cancer. Overview of newer agents. Hematology/oncology clinics of North America, 1999, Volume: 13, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids; Topotecan; Vinblastine; Vinorelbine	1999
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Life Tables; Male; Metabolic Clearance Rate; Middle Aged; Paclitaxel; Survival Analysis; Taxoids; Tomography, X-Ray Computed	1999
Taxanes in combined-modality therapy for solid tumors. Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:10 Suppl 5 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Paclitaxel; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids	1999
The chemotherapy of head and neck cancer. Acta oto-rhino-laryngologica Belgica, 1999, Volume: 53, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Paclitaxel; Taxoids	1999
Taxoids in head and neck cancer: the American approach. Acta oto-rhino-laryngologica Belgica, 1999, Volume: 53, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; United States	1999
[Recent regimen of chemotherapy for advanced head and neck carcinomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Paclitaxel; Prognosis; Taxoids	2000
Role of taxoids in head and neck cancer. The oncologist, 2000, Volume: 5, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Docetaxel; Head and Neck Neoplasms; Humans; Microtubules; Paclitaxel; Taxoids	2000
[Evidence for Taxotere treatment with solid tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Evidence-Based Medicine; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Stomach Neoplasms; Taxoids	2000
The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Seminars in oncology, 2000, Volume: 27, Issue:4 Suppl 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Decision Making; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Paclitaxel; Taxoids	2000
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Seminars in oncology, 2000, Volume: 27, Issue:4 Suppl 8 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	2000
Docetaxel in squamous cell cancer of the head and neck. Anti-cancer drugs, 2001, Volume: 12 Suppl 1 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Head and Neck Neoplasms; Humans; Paclitaxel; Taxoids	2001
[Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Paclitaxel; Prospective Studies; Taxoids; Thiosulfates	2002
[Current and future state of chemoradiotherapy for head and neck cancer]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2002, Volume: 62, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Organoplatinum Compounds; Paclitaxel; Taxoids	2002

Trials

141 trial(s) available for docetaxel anhydrous and Cancer of Head

Article	Year
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study. Oral oncology, 2022, Volume: 124 Topics: Antibodies, Monoclonal, Humanized; Docetaxel; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Prospective Studies; Squamous Cell Carcinoma of Head and Neck	2022
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial. Oncology research and treatment, 2022, Volume: 45, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Fatigue; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Quality of Life; Squamous Cell Carcinoma of Head and Neck	2022
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer. Oral oncology, 2022, Volume: 134 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome	2022
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer. Oral oncology, 2022, Volume: 134 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Taxoids	2022
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 05-01, Volume: 41, Issue:13 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Squamous Cell Carcinoma of Head and Neck; Taxoids	2023
L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy. Nutrients, 2023, Sep-23, Volume: 15, Issue:19 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Glutamine; Head and Neck Neoplasms; Humans	2023
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence. Oral oncology, 2023, Volume: 147 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Docetaxel; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Platinum; Squamous Cell Carcinoma of Head and Neck	2023
Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer. The Korean journal of internal medicine, 2021, Volume: 36, Issue:Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharynx; Induction Chemotherapy; Tongue Neoplasms	2021
Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study. BMC cancer, 2020, Sep-01, Volume: 20, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Squamous Cell Carcinoma of Head and Neck	2020
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302). Cancer medicine, 2020, Volume: 9, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Gefitinib; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Reported Outcome Measures; Predictive Value of Tests; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Symptom Assessment; Treatment Outcome	2020
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial. European journal of cancer (Oxford, England : 1990), 2021, Volume: 151 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Cetuximab; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Remission Induction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome	2021
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial. Medical oncology (Northwood, London, England), 2021, Aug-06, Volume: 38, Issue:9 Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pantoprazole; Prognosis; Proton Pump Inhibitors; Retrospective Studies	2021
Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Taxoids	2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Sep-01, Volume: 28, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; DNA, Viral; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; In Situ Hybridization; Male; Papillomaviridae; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids	2017
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England), 2019, 01-12, Volume: 393, Issue:10167 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck	2019
Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. Head & neck, 2019, Volume: 41, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Clinical Decision Rules; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Docetaxel; Endpoint Determination; Head and Neck Neoplasms; Humans; Progression-Free Survival; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Statistics as Topic	2019
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck. PharmacoEconomics, 2019, Volume: 37, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease Progression; Docetaxel; Follow-Up Studies; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Nivolumab; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Survival	2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck. International journal of radiation oncology, biology, physics, 2019, 09-01, Volume: 105, Issue:1 Topics: Adult; Afatinib; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypokalemia; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Mucositis; Postoperative Period; Prospective Studies; Radiotherapy Dosage	2019
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer, 2013, May-15, Volume: 119, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Everolimus; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Mutation; Neoplasm Staging; Papillomavirus Infections; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Risk Assessment; Risk Factors; Signal Transduction; Sirolimus; Smoking; Taxoids; TOR Serine-Threonine Kinases; Treatment Outcome	2013
Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study. Oncology, 2013, Volume: 84, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome	2013
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische Onkologie. Oncology, 2013, Volume: 84, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Time Factors; Treatment Outcome	2013
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Docetaxel; Drug Administration Schedule; ErbB Receptors; Fatigue; Female; Gefitinib; Genotype; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins; Taxoids; Treatment Outcome	2013
Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck. BMC cancer, 2013, Mar-06, Volume: 13 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Oxonic Acid; Quality of Life; Survival Analysis; Taxoids; Tegafur	2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN). Oral oncology, 2013, Volume: 49, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Piperidines; Quinazolines; Taxoids	2013
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Taxoids	2014
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck. Head & neck, 2015, Volume: 37, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Taxoids; Treatment Outcome	2015
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Aug-10, Volume: 32, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Postoperative Care; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Treatment Outcome	2014
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Sep-01, Volume: 32, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Induction Chemotherapy; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids	2014
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Dec-10, Volume: 32, Issue:35 Topics: Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Cyclin-Dependent Kinase Inhibitor p16; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunohistochemistry; Neoplasm Proteins; Papillomaviridae; Papillomavirus Infections; Prognosis; Smoking; Taxoids; Treatment Outcome	2014
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. Oral oncology, 2015, Volume: 51, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Female; Gonanes; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Taxoids	2015
Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck. Cancer medicine, 2015, Volume: 4, Issue:4 Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cause of Death; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome	2015
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck. International journal of radiation oncology, biology, physics, 2015, Apr-01, Volume: 91, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA, Viral; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Organ Sparing Treatments; Oropharyngeal Neoplasms; Papillomaviridae; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Stomatitis; Survival Rate; Taxoids	2015
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Taxoids	2015
A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer. The oncologist, 2015, Volume: 20, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Taxoids; Treatment Outcome	2015
Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-0 European journal of cancer (Oxford, England : 1990), 2016, Volume: 52 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Early Termination of Clinical Trials; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Netherlands; Radiotherapy Dosage; Risk Factors; Taxoids; Time Factors; Treatment Outcome	2016
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:2 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Child; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Taxoids; Treatment Outcome	2016
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck. International journal of radiation oncology, biology, physics, 2016, Feb-01, Volume: 94, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Taxoids	2016
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Organ Sparing Treatments; Squamous Cell Carcinoma of Head and Neck; Taxoids; Time Factors; Treatment Outcome	2016
Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head & neck, 2016, Volume: 38 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy, Intensity-Modulated; Taxoids	2016
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Early Termination of Clinical Trials; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Dosage; Severity of Illness Index; Taxoids	2016
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer. Investigational new drugs, 2016, Volume: 34, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Gossypol; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome	2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer. American journal of clinical oncology, 2018, Volume: 41, Issue:5 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Erlotinib Hydrochloride; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Survival Rate	2018
Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study. The Journal of laryngology and otology, 2016, Volume: 130, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Pilot Projects; Survival Analysis; Taxoids	2016
Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer. Scientific reports, 2016, 09-06, Volume: 6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Docetaxel; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Taxoids	2016
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck. Oral oncology, 2016, Volume: 61 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Panitumumab; Squamous Cell Carcinoma of Head and Neck; Taxoids	2016
[Docetaxel (TXT) and irinotecan (CPT-11) as a second-line chemotherapy for platinum-pretreated squamous cell carcinoma of the head and neck]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Platinum; Taxoids	2008
Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Survival Rate; Taxoids; Tomography, X-Ray Computed	2008
Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Palliative Care; Quality of Life; Recurrence; Survival Analysis; Taxoids	2009
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck. Cancer, 2009, May-15, Volume: 115, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Quinazolines; Remission Induction; Taxoids; Treatment Outcome	2009
Outpatient chemotherapy with S-1 for recurrent head and neck cancer. Anticancer research, 2009, Volume: 29, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Taxoids; Tegafur	2009
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck. Cancer chemotherapy and pharmacology, 2009, Volume: 65, Issue:1 Topics: Adult; Aged; Anemia; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Taxoids	2009
Phase I adjuvant radiation with docetaxel in high-risk head and neck cancer. American journal of clinical oncology, 2009, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Risk Assessment; Survival Analysis; Taxoids; Treatment Outcome	2009
Single tissue samples from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel. Onkologie, 2009, Volume: 32, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Treatment Outcome	2009
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria Head & neck, 2010, Volume: 32, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Taxoids	2010
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Cancer, 2009, Oct-01, Volume: 115, Issue:19 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cyclooxygenase 2; Docetaxel; Drug Administration Schedule; Female; Glucuronosyltransferase; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Vascular Endothelial Growth Factor A	2009
[A Phase II study of docetaxel and cisplatin in patients with recurrent or unresectable squamous cell carcinoma of the head and neck]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids	2009
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-20, Volume: 27, Issue:27 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Taxoids	2009
Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck. Head & neck, 2009, Volume: 31, Issue:10 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cost of Illness; Cost-Benefit Analysis; Disease Progression; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Markov Chains; Neoadjuvant Therapy; Quality of Life; Quality-Adjusted Life Years; Radiation-Sensitizing Agents; Taxoids; United Kingdom	2009
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Docetaxel; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; NF-kappa B; Pyrazines; Recurrence; Signal Transduction; Survival Analysis; Taxoids; Treatment Outcome	2010
beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Dec-20, Volume: 27, Issue:36 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Taxoids; Treatment Outcome; Tubulin	2009
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Remission Induction; Survival Rate; Taxoids; Treatment Outcome	2010
Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Taxoids	2009
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93). Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Hospitals, University; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Taxoids; Treatment Outcome	2010
Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy. European journal of cancer care, 2011, Volume: 20, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Remission Induction; Squamous Cell Carcinoma of Head and Neck; Taxoids	2011
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN). Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Chromatography, Liquid; Docetaxel; Dose-Response Relationship, Drug; Enzyme Induction; Erlotinib Hydrochloride; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Quinazolines; Tandem Mass Spectrometry; Taxoids	2011
Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxonic Acid; Taxoids; Tegafur; Young Adult	2011
A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers. Cancer investigation, 2010, Volume: 28, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Case-Control Studies; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome	2010
A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer. Auris, nasus, larynx, 2011, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Taxoids; Treatment Outcome	2011
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). British journal of cancer, 2010, Oct-12, Volume: 103, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Health Status; Humans; Quality of Life; Taxoids; Time Factors; Treatment Outcome	2010
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. American journal of clinical oncology, 2011, Volume: 34, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Squamous Cell; Cohort Studies; Docetaxel; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Taxoids; Treatment Outcome	2011
Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future? The oncologist, 2010, Volume: 15 Suppl 3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Taxoids; United States	2010
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. The Lancet. Oncology, 2011, Volume: 12, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Taxoids	2011
Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. International journal of radiation oncology, biology, physics, 2011, Dec-01, Volume: 81, Issue:5 Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Radiotherapy Dosage; Severity of Illness Index; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Time Factors	2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Taxoids	2011
Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2011, Volume: 13, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Radiotherapy; Taxoids	2011
[Preventive effect of polaprezinc suspension dispersed in sodium alginate solution (P-AG) for stomatitis induced by Docetaxel/Cisplatin/Fluorouracil (DCF) chemotherapy in patients with head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:5 Topics: Adult; Aged; Alginates; Antineoplastic Combined Chemotherapy Protocols; Carnosine; Cisplatin; Docetaxel; Dosage Forms; Female; Fluorouracil; Glucuronic Acid; Head and Neck Neoplasms; Hexuronic Acids; Humans; Male; Middle Aged; Organometallic Compounds; Solutions; Stomatitis; Taxoids; Zinc Compounds	2011
Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Aug-01, Volume: 17, Issue:15 Topics: Amphiregulin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Docetaxel; EGF Family of Proteins; ErbB Receptors; Glycoproteins; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome	2011
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer. Oral oncology, 2011, Volume: 47, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Cetuximab; Chemokines; Cisplatin; Cytokines; Disease-Free Survival; Docetaxel; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-6; Male; Middle Aged; Prognosis; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A; Young Adult	2011
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzamides; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chi-Square Distribution; Disease-Free Survival; Docetaxel; Early Termination of Clinical Trials; Female; Gene Dosage; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Piperazines; Proportional Hazards Models; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Taxoids	2011
Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer. Head & neck, 2012, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Maximum Tolerated Dose; Middle Aged; Taxoids; Treatment Outcome	2012
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2012
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Taxoids	2013
Hyperfractionated radiotherapy with concurrent docetaxel for advanced head and neck cancer: a phase II study. Anticancer research, 2012, Volume: 32, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck; Taxoids	2012
RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatin. Onkologie, 2012, Volume: 35, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Neoplasm Recurrence, Local; Prognosis; Republic of Korea; Risk Factors; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome; Tumor Suppressor Proteins	2012
Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial. Cancer, 2002, Jun-01, Volume: 94, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome	2002
Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Irinotecan; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Paclitaxel; Taxoids; Treatment Outcome	2002
A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck. Cancer, 2002, Oct-01, Volume: 95, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Paclitaxel; Taxoids	2002
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Oncology, 2002, Volume: 63, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Palliative Care; Recurrence; Survival Rate; Taxoids; Time Factors	2002
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer. Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Survival Analysis; Taxoids; Topotecan	2003
Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. American journal of clinical oncology, 2003, Volume: 26, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Squamous Cell; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2003
Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer. Japanese journal of clinical oncology, 2003, Volume: 33, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Mucosa; Neoplasm Staging; Paclitaxel; Radiation-Sensitizing Agents; Stomatitis; Taxoids	2003
Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients. Anti-cancer drugs, 2003, Volume: 14, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Taxoids	2003
Efficacy of intra-arterial infusion therapy using a combination of cisplatin and docetaxel for recurrent head and neck cancers compared with cisplatin alone. Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome	2003
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Squamous Cell; Stomatitis; Survival Analysis; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome	2004
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study. American journal of clinical oncology, 2004, Volume: 27, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Survival Analysis; Taxoids; Treatment Outcome	2004
Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. International journal of clinical oncology, 2004, Volume: 9, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Taxoids; Treatment Outcome	2004
Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. International journal of radiation oncology, biology, physics, 2004, Jun-01, Volume: 59, Issue:2 Topics: Adult; Aged; Anemia; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Radiotherapy Dosage; Stomatitis; Taxoids; Thrombocytopenia	2004
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Diarrhea; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Squamous Cell; Neutropenia; Organoplatinum Compounds; Prostatic Neoplasms; Taxoids; Treatment Outcome	2004
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. European journal of cancer (Oxford, England : 1990), 2004, Volume: 40, Issue:14 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Taxoids; Treatment Outcome	2004
Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study. American journal of clinical oncology, 2004, Volume: 27, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Taxoids	2004
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2005, Volume: 181, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Head; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Neck; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Taxoids; Thiosulfates; Time Factors; Treatment Outcome	2005
Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. International journal of radiation oncology, biology, physics, 2005, Apr-01, Volume: 61, Issue:5 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy Dosage; Taxoids	2005
Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer, 2005, Jun-15, Volume: 103, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Rate; Taxoids; Treatment Outcome	2005
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome	2005
[A Phase I study of docetaxel and cisplatin for advanced squamous cell carcinoma of the head and neck]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Taxoids	2005
Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Cancer, 2006, Jan-01, Volume: 106, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Taxoids; Treatment Outcome	2006
Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer. The Laryngoscope, 2006, Volume: 116, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Quality of Life; Survival Rate; Taxoids; Treatment Outcome	2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. International journal of radiation oncology, biology, physics, 2006, Jul-15, Volume: 65, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Radiotherapy Dosage; Remission Induction; Taxoids	2006
Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Oral oncology, 2006, Volume: 42, Issue:7 Topics: Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiotherapy; Remission Induction; Sex Distribution; Survival Analysis; Taxoids; Treatment Outcome	2006
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Sep-01, Volume: 24, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Analysis; Taxoids; Treatment Outcome	2006
[Phase I/II clinical trial of induction chemotherapy with nedaplatin (CDGP), docetaxel (DOC) and 5-fluorouracil (5-FU) for squamous cell carcinoma of head and neck]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Quality of Life; Taxoids	2007
A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients. International journal of radiation oncology, biology, physics, 2007, Apr-01, Volume: 67, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Erythropoietin; Female; Head and Neck Neoplasms; Hemoglobin A; Humans; Male; Middle Aged; Mouth Mucosa; Prospective Studies; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Stomatitis; Taxoids	2007
Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Docetaxel; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Pharynx; Radiotherapy; Radiotherapy Dosage; Taxoids; Time Factors; Treatment Outcome	2007
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study. American journal of clinical oncology, 2007, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Recurrence; Taxoids; Treatment Outcome	2007
Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Head & neck, 2007, Volume: 29, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Taxoids	2007
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer investigation, 2007, Volume: 25, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis; Taxoids	2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England journal of medicine, 2007, Oct-25, Volume: 357, Issue:17 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiotherapy; Survival Analysis; Taxoids	2007
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. The New England journal of medicine, 2007, Oct-25, Volume: 357, Issue:17 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy; Survival Analysis; Taxoids; Treatment Outcome	2007
Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer. International journal of radiation oncology, biology, physics, 2008, May-01, Volume: 71, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiotherapy Dosage; Remission Induction; Taxoids	2008
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Epothilones; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Recurrence; Salvage Therapy; Survival Analysis; Taxoids	2008
Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of immunotherapy (Hagerstown, Md. : 1997), 2008, Volume: 31, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; CD4-CD8 Ratio; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Immunotherapy; Killer Cells, Natural; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; T-Lymphocytes; Taxoids	2008
p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma. Auris, nasus, larynx, 2009, Volume: 36, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Phosphorylation; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Taxoids; Tumor Suppressor Protein p53	2009
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A Suppl 4 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged; Neoplasms; Paclitaxel; Sarcoma; Stomach Neoplasms; Taxoids	1995
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:6 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Asthenia; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Europe; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1994
Docetaxel: an active drug for squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Treatment Outcome	1996
Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas. Anti-cancer drugs, 1995, Volume: 6 Suppl 4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Sarcoma; Taxoids	1995
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors. Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:8 Suppl 8 Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclophosphamide; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Premedication; Remission Induction; Sarcoma; Taxoids	1997
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Middle Aged; Paclitaxel; Taxoids	1998
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Remission Induction; Taxoids	1999
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Survival Rate; Taxoids; Treatment Outcome	1999
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Life Tables; Male; Metabolic Clearance Rate; Middle Aged; Paclitaxel; Survival Analysis; Taxoids; Tomography, X-Ray Computed	1999
Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2000, Volume: 176, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Taxoids; Time Factors; Treatment Outcome	2000
Combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer: a phase II feasibility study. American journal of clinical oncology, 2000, Volume: 23, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Recurrence; Taxoids	2000
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease Progression; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Palliative Care; Taxoids; Treatment Outcome	2000
Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Survival Analysis; Taxoids	2000
Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-15, Volume: 19, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hypocalcemia; Magnesium; Male; Middle Aged; Paclitaxel; Remission Induction; Taxoids	2001
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Survival Rate; Taxoids; Treatment Outcome	2001
Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer. American journal of clinical oncology, 2001, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Taxoids	2001
A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions. Farmaco (Societa chimica italiana : 1989), 2001, Volume: 56, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Area Under Curve; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Interactions; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	2001
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Mar-15, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome	2002
Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN). American journal of clinical oncology, 2002, Volume: 25, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Paclitaxel; Taxoids	2002

Other Studies

208 other study(ies) available for docetaxel anhydrous and Cancer of Head

Article	Year
An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of medicinal chemistry, 2015, Dec-10, Volume: 58, Issue:23 Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Proliferation; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Heterografts; Humans; Indoles; Male; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Structure-Activity Relationship; Tubulin; Tubulin Modulators	2015
Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2022, Volume: 47, Issue:1 Topics: Aged; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Head and Neck Neoplasms; Humans; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck	2022
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients. Oral oncology, 2022, Volume: 130 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans	2022
Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer. Cancer medicine, 2023, Volume: 12, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Taxoids	2023
Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma. Head & neck, 2022, Volume: 44, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Laryngectomy; Larynx; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids	2022
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy. Science translational medicine, 2022, 09-07, Volume: 14, Issue:661 Topics: Docetaxel; Head and Neck Neoplasms; Humans; Pharmacogenetics; Precision Medicine; Squamous Cell Carcinoma of Head and Neck	2022
Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling. JCI insight, 2022, 12-08, Volume: 7, Issue:23 Topics: Animals; Docetaxel; Head and Neck Neoplasms; Humans; Intercellular Adhesion Molecule-1; Interleukin-1beta; Macrophages; Mice; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment	2022
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy. BMC cancer, 2022, Oct-21, Volume: 22, Issue:1 Topics: Alanine Transaminase; Body Composition; Docetaxel; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Platinum; Retrospective Studies	2022
Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer. Anticancer research, 2022, Volume: 42, Issue:12 Topics: Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Prognosis; Treatment Outcome	2022
Docetaxel plus radiotherapy for head and neck cancer. Oral oncology, 2023, Volume: 139 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans	2023
Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma. Cancer investigation, 2023, Volume: 41, Issue:5 Topics: Animals; CD8-Positive T-Lymphocytes; Curcumin; Docetaxel; Head and Neck Neoplasms; Humans; Immunity; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment	2023
Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas. Radiation oncology (London, England), 2023, May-26, Volume: 18, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tongue Neoplasms	2023
[Definitive radiotherapy versus radiochemotherapy with weekly docetaxel in patients with head and neck cancer and cisplatin intolerance]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2023, Volume: 199, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans	2023
Oncological outcomes of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced squamous cell carcinoma of the external auditory canal: A single-center study. Head & neck, 2023, Volume: 45, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Ear Canal; Fluorouracil; Head and Neck Neoplasms; Humans; Retrospective Studies; Taxoids	2023
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. Neoplasia (New York, N.Y.), 2023, Volume: 45 Topics: Carcinoma, Squamous Cell; Docetaxel; Head and Neck Neoplasms; HMGB1 Protein; Humans; Papillomavirus Infections; Phenotype; Squamous Cell Carcinoma of Head and Neck	2023
Platelet-lymphocyte and neutrophil-lymphocyte ratios: Predictive factors of response and toxicity for docetaxel-combined induction chemotherapy in advanced head and neck cancers. Journal of the Chinese Medical Association : JCMA, 2019, Volume: 82, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Docetaxel; Female; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymphocytes; Male; Middle Aged; Neutrophils; Retrospective Studies	2019
Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer. Nagoya journal of medical science, 2019, Volume: 81, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Treatment Outcome	2019
Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1). Oral oncology, 2020, Volume: 100 Topics: Adult; Aged; Carboplatin; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Retrospective Studies; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome	2020
Does a simple hematological examination predict the response and side effects in patients undergoing induction chemotherapy and/or neoadjuvant chemotherapy? Journal of the Chinese Medical Association : JCMA, 2020, Volume: 83, Issue:2 Topics: Chemotherapy, Adjuvant; Docetaxel; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymphocytes; Neoadjuvant Therapy; Neutrophils	2020
Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types). Asian Pacific journal of cancer prevention : APJCP, 2020, Mar-01, Volume: 21, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2020
Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance. Asian Pacific journal of cancer prevention : APJCP, 2020, May-01, Volume: 21, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Patient Compliance; Prognosis; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Young Adult	2020
Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity. Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:10 Topics: Antineoplastic Agents; Cell Hypoxia; Cell Survival; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Organ Culture Techniques; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured	2020
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil. International journal of clinical oncology, 2020, Volume: 25, Issue:11 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Paclitaxel; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2020
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Confidence Intervals; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Intention to Treat Analysis; Laryngeal Neoplasms; Mouth Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Tumor Burden	2021
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01). BMC cancer, 2020, Aug-27, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Young Adult	2020
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience. Anti-cancer drugs, 2020, Volume: 31, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Papillomavirus Infections; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2020
Drinking Ice-Cold Water Reduces the Severity of Anticancer Drug-Induced Taste Dysfunction in Mice. International journal of molecular sciences, 2020, Nov-25, Volume: 21, Issue:23 Topics: Animals; Cell Proliferation; Cisplatin; Disease Models, Animal; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Ice; Mice; Taste Disorders; Taxoids; Water	2020
Are taxanes the future for head and neck cancer? Pragmatism in the immunotherapy era. The Lancet. Oncology, 2021, Volume: 22, Issue:4 Topics: Cetuximab; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Platinum; Taxoids	2021
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences, 2021, Mar-17, Volume: 22, Issue:6 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CCL20; Docetaxel; Head and Neck Neoplasms; Humans; Mice, Nude; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2021
Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01). Cancer research and treatment, 2022, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck	2022
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients. Cancer medicine, 2021, Volume: 10, Issue:14 Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Agents; Docetaxel; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Pharmacogenomic Variants; Polymorphism, Genetic; Prostatic Neoplasms; Reference Values; Young Adult	2021
Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5-fluorouracil combination induction chemotherapy in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2021, Volume: 50, Issue:8 Topics: Annexin A1; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids	2021
Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients. European journal of cancer (Oxford, England : 1990), 2021, Volume: 156 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Databases, Factual; Disease Progression; Docetaxel; Europe; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Risk Assessment; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Time Factors	2021
Livin enhances chemoresistance in head and neck squamous cell carcinoma. Oncology reports, 2017, Volume: 37, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Head and Neck Neoplasms; Humans; Inhibitor of Apoptosis Proteins; Neoplasm Proteins; Squamous Cell Carcinoma of Head and Neck; Taxoids	2017
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer. International journal of cancer, 2017, 09-15, Volume: 141, Issue:6 Topics: Animals; Antineoplastic Agents; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cetuximab; DNA Mutational Analysis; Docetaxel; ErbB Receptors; Everolimus; Fluorouracil; Gene Expression; Head and Neck Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Mice; Mice, Inbred NOD; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Xenograft Model Antitumor Assays	2017
Squamous cell carcinoma of neck metastasized to the lung and cervical lymph nodes, successfully treated with systemic docetaxel and local radiation therapy to the neck in a renal transplant patient. The Journal of dermatology, 2017, Volume: 44, Issue:12 Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male	2017
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy. PloS one, 2018, Volume: 13, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Prognosis; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Survival Rate; Taxoids	2018
A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma. Medical science monitor : international medical journal of experimental and clinical research, 2018, Apr-26, Volume: 24 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Carcinoma; Chemoradiotherapy; China; Cisplatin; Disease-Free Survival; Docetaxel; Endostatins; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy; Retrospective Studies; Taxoids	2018
Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The Korean journal of internal medicine, 2019, Volume: 34, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Time Factors	2019
PD-1 antibodies in head-and-neck cancer. Lancet (London, England), 2019, 01-12, Volume: 393, Issue:10167 Topics: Antibodies, Monoclonal, Humanized; Cetuximab; Docetaxel; Head and Neck Neoplasms; Humans; Methotrexate; Programmed Cell Death 1 Receptor	2019
Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral oncology, 2018, Volume: 87 Topics: Animals; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Screening Assays, Antitumor; Female; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Male; Mice; Organoids; Primary Cell Culture; Spheroids, Cellular; Squamous Cell Carcinoma of Head and Neck; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2018
Towards risk-stratified induction regimens. Nature reviews. Clinical oncology, 2019, Volume: 16, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Paclitaxel; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome	2019
Tumor volume as a predictive parameter in the sequential therapy (induction chemotherapy) of head and neck squamous cell carcinomas. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019, Volume: 276, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Remission Induction; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tumor Burden; Young Adult	2019
[Toxicity of docetaxel, platine, 5-fluorouracil-based induction chemotherapy for locally advanced head and neck cancer: The importance of nutritional status]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2019, Volume: 23, Issue:4 Topics: Adult; Age Factors; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Enteral Nutrition; Febrile Neutropenia; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infections; Male; Middle Aged; Nutritional Status; Retrospective Studies; Thrombocytopenia; Tumor Burden; Weight Loss	2019
Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients. Anticancer research, 2019, Volume: 39, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; C-Reactive Protein; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hyponatremia; Incidence; Induction Chemotherapy; Inflammation Mediators; Japan; Lymphocyte Count; Male; Middle Aged; Nutritional Status; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Serum Albumin, Human; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome	2019
[Pembrolizumab is more effective and better tolerable than methotrexate, docetaxel, or cetuximab in recurrent or metastatic HNSCC (KEYNOTE-040)]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2019, Volume: 195, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Cetuximab; Docetaxel; Head and Neck Neoplasms; Humans; Methotrexate; Squamous Cell Carcinoma of Head and Neck	2019
Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer. Anticancer research, 2019, Volume: 39, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis	2019
Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Taxoids	2013
Survival impact of pulmonary metastasectomy for patients with head and neck cancer. Head & neck, 2013, Volume: 35, Issue:12 Topics: Adenoma; Antineoplastic Agents; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Lung Neoplasms; Male; Metastasectomy; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Pneumonectomy; Prognosis; Retrospective Studies; Taxoids; Thoracotomy	2013
Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro. Anticancer research, 2013, Volume: 33, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Viral; Docetaxel; Enzyme-Linked Immunosorbent Assay; Fluorouracil; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Immunoenzyme Techniques; In Vitro Techniques; Papillomavirus Infections; Platelet-Derived Growth Factor; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2013
Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Taxoids	2013
Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Retrospective Studies; Risk Factors; Taxoids	2013
Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects. Anticancer research, 2013, Volume: 33, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Hedgehog Proteins; Humans; KB Cells; Keratins; Male; Molecular Targeted Therapy; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor; Taxoids; Tumor Cells, Cultured; Tumor Stem Cell Assay; Veratrum Alkaloids	2013
Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Anticancer research, 2013, Volume: 33, Issue:6 Topics: Antimetabolites; Antineoplastic Agents; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Enzyme-Linked Immunosorbent Assay; Fluorouracil; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Immunohistochemistry; Papillomavirus Infections; Proto-Oncogene Proteins c-kit; Signal Transduction; Taxoids; Wnt Signaling Pathway	2013
Toxicity of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for advanced head and neck cancer. The Israel Medical Association journal : IMAJ, 2013, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Feasibility Studies; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Taxoids	2013
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck. Head and neck pathology, 2014, Volume: 8, Issue:1 Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tubulin	2014
Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology, 2013, Volume: 269, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Contrast Media; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk Factors; Software; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2013
The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis. Clinical oncology (Royal College of Radiologists (Great Britain)), 2013, Volume: 25, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Matched-Pair Analysis; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids; Treatment Outcome	2013
The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome	2013
Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Oral oncology, 2014, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids	2014
Strategies for non-resectable head and neck cancer. Current treatment options in oncology, 2013, Volume: 14, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Patient Care Team; Patient Selection; Practice Patterns, Physicians'; Radiotherapy, Intensity-Modulated; Speech Disorders; Survival Analysis; Taxoids; Treatment Outcome	2013
TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. Head & neck, 2014, Volume: 36, Issue:11 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Induction Chemotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Survival Analysis; Taxoids; Treatment Outcome	2014
Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance. British journal of cancer, 2014, Jan-21, Volume: 110, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Culture Techniques; Cell Nucleus; Cetuximab; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Squamous Cell Carcinoma of Head and Neck; Taxoids	2014
PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel. Head & neck, 2015, Volume: 37, Issue:4 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cetuximab; Class I Phosphatidylinositol 3-Kinases; Docetaxel; Female; Genotype; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Squamous Cell Carcinoma of Head and Neck; Taxoids; TOR Serine-Threonine Kinases; Treatment Outcome	2015
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:4 Topics: Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; KB Cells; Male; Neoplasm Staging; Risk Factors; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Taxoids	2014
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck. Japanese journal of clinical oncology, 2014, Volume: 44, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Taxoids; Treatment Outcome	2014
Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study. The British journal of dermatology, 2014, Volume: 171, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Chemoradiotherapy; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Scalp; Skin Neoplasms; Taxoids; Treatment Outcome	2014
Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:10 Topics: Aged; Antineoplastic Agents; Antineoplastic Protocols; Cisplatin; Docetaxel; Drug Therapy, Combination; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Taxoids	2014
A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cisplatin; Docetaxel; Drugs, Chinese Herbal; Female; Head and Neck Neoplasms; Humans; Japan; Male; Medicine, East Asian Traditional; Middle Aged; Mucositis; Quality of Life; Retrospective Studies; Stomatitis; Taxoids	2015
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma. Anticancer research, 2014, Volume: 34, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids	2014
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma. International journal of clinical oncology, 2015, Volume: 20, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Retrospective Studies; Taxoids; Treatment Outcome	2015
Effects of D-allose in combination with docetaxel in human head and neck cancer cells. International journal of oncology, 2014, Volume: 45, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Docetaxel; Glucose; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Taxoids	2014
Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro. Anticancer research, 2014, Volume: 34, Issue:9 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Docetaxel; Fluorouracil; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Squamous Cell Carcinoma of Head and Neck; Taxoids	2014
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases. International journal of clinical oncology, 2015, Volume: 20, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Taxoids; Treatment Outcome	2015
Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC. The Laryngoscope, 2015, Volume: 125, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Count; Cell Line, Tumor; Cell Proliferation; Dipeptides; Docetaxel; Drug Therapy, Combination; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Mice; Mitochondrial Proteins; Neoplasms, Experimental; Squamous Cell Carcinoma of Head and Neck; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2015
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy. Auris, nasus, larynx, 2015, Volume: 42, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids	2015
Role of induction chemotherapy for N3 head and neck squamous cell carcinoma. Auris, nasus, larynx, 2015, Volume: 42, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids	2015
[Recurrence sites following definitive intensity-modulated conformational radiotherapy of squamous-cell carcinomas of the upper aerodigestive tract]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids	2015
Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma. Auris, nasus, larynx, 2015, Volume: 42, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Taxoids	2015
Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience. Auris, nasus, larynx, 2015, Volume: 42, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Endoscopy; Ethmoid Sinus; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids	2015
Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients. Radiation oncology (London, England), 2015, Apr-18, Volume: 10 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Docetaxel; Enteral Nutrition; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids	2015
Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Head & neck, 2016, Volume: 38 Suppl 1 Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Mice, Nude; Middle Aged; Taxoids; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2016
Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study. International journal of clinical oncology, 2015, Volume: 20, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Palliative Care; Remission Induction; Retrospective Studies; Taxoids; Treatment Outcome	2015
Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines. Molecular medicine reports, 2015, Volume: 12, Issue:2 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Multidrug Resistance-Associated Proteins; RNA, Messenger; Taxoids	2015
Glycosaminoglycan and versican deposits in taxane-induced sclerosis. The British journal of dermatology, 2015, Volume: 173, Issue:4 Topics: Docetaxel; Glycosaminoglycans; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Middle Aged; Scalp; Scleroderma, Localized; Sclerosis; Skin Neoplasms; Taxoids; Versicans	2015
Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma. Cell death & disease, 2015, May-28, Volume: 6 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Imidazoles; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Lysosomal-Associated Membrane Protein 2; Membrane Proteins; Mice; Mice, Knockout; Mice, Nude; Microtubule-Associated Proteins; Mitochondria; Naphthoquinones; Phosphorylation; Retinoblastoma Protein; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Survivin; Tamoxifen; Taxoids; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2015
Long-term remission of locally recurrent oropharyngeal cancer after docetaxel-based chemotherapy plus cetuximab. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016, Volume: 273, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Quality of Life; Remission Induction; Taxoids; Time Factors; Tonsillar Neoplasms; Treatment Outcome	2016
Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2015, Volume: 14, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Taxoids; Tumor Burden	2015
Olfaction in chemotherapy for head and neck malignancies. Auris, nasus, larynx, 2016, Volume: 43, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Controlled Before-After Studies; Differential Threshold; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Olfaction Disorders; Pharyngeal Neoplasms; Prospective Studies; Sensory Thresholds; Smoking; Squamous Cell Carcinoma of Head and Neck; Taxoids	2016
Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment. Acta oto-laryngologica, 2016, Volume: 136, Issue:2 Topics: Antineoplastic Agents; Dexamethasone; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Head and Neck Neoplasms; Humans; Male; Neoplasm Staging; Premedication; Retrospective Studies; Taxoids; Time Factors; Treatment Outcome	2016
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer. BMC cancer, 2015, Oct-16, Volume: 15 Topics: Adult; Aged; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Genotype; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Steroid Hydroxylases; Taxoids	2015
[Determination of the Appropriate Timing of Aprepitant Administration for Nausea in Patients with Head and Neck Cancer Receiving Combination Chemotherapy with Docetaxel, Nedaplatin（Divided Doses for 5 Days), and 5-fluorouracil]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Morpholines; Nausea; Organoplatinum Compounds; Taxoids; Time Factors	2015
Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes. Anticancer research, 2015, Volume: 35, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Time Factors	2015
STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell. Oncotarget, 2015, Dec-08, Volume: 6, Issue:39 Topics: Aminosalicylic Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Self Renewal; Cell Survival; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Humans; Mice, Knockout; Mice, Nude; Neoplastic Stem Cells; Phenotype; Phosphorylation; Side-Population Cells; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Taxoids; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays	2015
Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma. Head & neck, 2016, Volume: 38 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Oxonic Acid; Taxoids; Tegafur; Young Adult	2016
[Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; France; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Taxoids; Young Adult	2016
Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. The Korean journal of internal medicine, 2016, Volume: 31, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Docetaxel; Eye; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Medical Records; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nose Neoplasms; Organ Sparing Treatments; Paranasal Sinus Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Taxoids; Time Factors; Treatment Outcome; Young Adult	2016
Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2017, Feb-01, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Early Detection of Cancer; Endoscopy, Digestive System; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Retrospective Studies; Taxoids; Treatment Outcome	2017
Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World journal of surgical oncology, 2016, Mar-22, Volume: 14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Areca; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Smoking; Survival Rate; Taxoids	2016
Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases. Head & neck, 2016, Volume: 38, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Computed Tomography Angiography; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Proton Therapy; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Survival Analysis; Taxoids; Treatment Outcome	2016
NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. Scientific reports, 2016, 04-25, Volume: 6 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Self Renewal; Cisplatin; Diamines; Docetaxel; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Receptor, Notch1; RNA, Small Interfering; Taxoids; Thiazoles; Xenograft Model Antitumor Assays	2016
Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients. Oncotarget, 2016, Jun-14, Volume: 7, Issue:24 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Frail Elderly; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Taxoids	2016
ERCC1 Expression Can Predict Response to Platinum-Based Induction Chemotherapy in Head and Neck Cancer Cases. Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:S3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Real-Time Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids	2016
Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy. Cancer science, 2016, Volume: 107, Issue:8 Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunologic Memory; Lymphocyte Activation; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes, Regulatory; Taxoids	2016
Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fever; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Liver; Male; Middle Aged; Neutropenia; Risk Factors; Taxoids; Ultrasonography	2016
The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors. Pathology oncology research : POR, 2017, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA Damage; DNA Repair; Docetaxel; Down-Regulation; Female; Fluorodeoxyglucose F18; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Radiotherapy Dosage; Squamous Cell Carcinoma of Head and Neck; Taxoids; Up-Regulation	2017
Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma. American journal of clinical pathology, 2016, Nov-01, Volume: 146, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p16; Docetaxel; Female; Fluorouracil; France; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymphocytes; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Prognosis; Taxoids; Tumor Suppressor Protein p53	2016
Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dietary Supplements; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Kidney Diseases; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Male; Middle Aged; Premedication; Retrospective Studies; Taxoids	2017
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy. International journal of radiation oncology, biology, physics, 2016, 12-01, Volume: 96, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha	2016
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma. Cancer medicine, 2017, Volume: 6, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Paclitaxel; Prognosis; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Taxoids; Treatment Outcome; Young Adult	2017
Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel. Medical oncology (Northwood, London, England), 2017, Volume: 34, Issue:2 Topics: Adult; Aged; Albumin-Bound Paclitaxel; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Polyethylene Glycols; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids	2017
Case of angiosarcoma of the scalp successfully controlled by eribulin. The Journal of dermatology, 2018, Volume: 45, Issue:1 Topics: Aged; Chemoradiotherapy; Docetaxel; Furans; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Ketones; Male; Neoplasm Recurrence, Local; Scalp; Skin; Skin Neoplasms; Treatment Outcome	2018
Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2008, Volume: 33, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Hemoglobins; Humans; Male; Middle Aged; Prognosis; Survival Rate; Taxoids; Treatment Outcome	2008
Treatment for lung metastasis from head and neck squamous cell carcinoma: a preliminary study of docetaxel. Oral and maxillofacial surgery, 2008, Volume: 12, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Prognosis; Retrospective Studies; Taxoids	2008
In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:2 Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Cycle; Cell Death; Cell Line, Tumor; Combined Modality Therapy; DNA, Complementary; Docetaxel; ErbB Receptors; Gene Expression Profiling; Gene Expression Regulation; Head and Neck Neoplasms; Humans; Oligonucleotide Array Sequence Analysis; Taxoids; Tumor Suppressor Protein p53	2009
Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck. Anticancer research, 2009, Volume: 29, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Gene Amplification; Genes, erbB-2; Head and Neck Neoplasms; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Remission Induction; Taxoids	2009
Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Retrospective Studies; Survival Rate; Taxoids; Tubulin; Tumor Suppressor Protein p53	2009
Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity. International journal of radiation oncology, biology, physics, 2010, Volume: 76, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Middle Aged; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Taxoids; Tumor Burden	2010
Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer. Molecular cancer research : MCR, 2009, Volume: 7, Issue:9 Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Chlorocebus aethiops; Cisplatin; COS Cells; Cytoskeletal Proteins; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HeLa Cells; Humans; Immunohistochemistry; Mice; NIH 3T3 Cells; Signal Transduction; src-Family Kinases; Taxoids; Ubiquitin-Conjugating Enzymes	2009
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epithelial Cells; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Stromal Cells; Taxoids; Tumor Cells, Cultured; Tumor Stem Cell Assay	2010
A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck. International journal of radiation oncology, biology, physics, 2010, Jun-01, Volume: 77, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Clinical Protocols; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; France; Head and Neck Neoplasms; Hospitalization; Humans; Male; Middle Aged; Radiodermatitis; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Stomatitis; Taxoids; Weight Loss	2010
Successful treatment of syncope with chemotherapy irresponsive to cardiac pacemaker in head and neck cancer. Yonsei medical journal, 2009, Oct-31, Volume: 50, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pacemaker, Artificial; Radiography; Syncope; Taxoids; Tonsillar Neoplasms	2009
Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Jan-01, Volume: 16, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Disease-Free Survival; Docetaxel; Exanthema; Female; Genes, erbB-1; Head and Neck Neoplasms; Humans; Male; Middle Aged; Polymorphism, Genetic; Survival Analysis; Taxoids; Treatment Outcome	2010
Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells? Anticancer research, 2010, Volume: 30, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Dexamethasone; Docetaxel; Drug Interactions; Head and Neck Neoplasms; Humans; Taxoids	2010
[In reference to the article: "Neck dissection following chemoradiation for node positive head and neck carcinomas" by Thariat et al. Cancer Radiother 2009;13:758-770]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2010, Volume: 14, Issue:3 Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Papillomavirus Infections; Radiotherapy, Adjuvant; Taxoids; Treatment Outcome	2010
Docetaxel suppresses invasiveness of head and neck cancer cells in vitro. Cancer science, 2010, Volume: 101, Issue:6 Topics: Antineoplastic Agents, Phytogenic; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Proliferation; Docetaxel; Head and Neck Neoplasms; Humans; Neoplasm Invasiveness; Spheroids, Cellular; Taxoids; Tubulin	2010
Pre-radiation enhances the cytotoxicity of docetaxel in head and neck squamous cell carcinoma cells. Oncology reports, 2010, Volume: 23, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemotherapy, Adjuvant; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Head and Neck Neoplasms; Humans; Mutation; Radiotherapy, Adjuvant; Taxoids; Time Factors; Tumor Suppressor Protein p53	2010
Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2010, Volume: 186, Issue:5 Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Taxoids	2010
XRP6258-induced gene expression patterns in head and neck cancer carcinoma. The Laryngoscope, 2010, Volume: 120, Issue:6 Topics: Annexin A5; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cyclin A; Cyclin B1; Docetaxel; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Phosphorylation; Taxoids; Tumor Cells, Cultured	2010
Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer. International journal of radiation oncology, biology, physics, 2011, Apr-01, Volume: 79, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Staging; Survival Rate; Taxoids; Temporal Arteries; Treatment Outcome	2011
[Treatment of advanced head and neck cancer by TPF]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Staging; Taxoids	2010
[Effectiveness of concurrent chemoradiation therapy using TPF]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Survival Rate; Taxoids; Treatment Outcome	2010
Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel. The British journal of dermatology, 2010, Volume: 163, Issue:6 Topics: Aged; Antineoplastic Agents; Biopsy; Docetaxel; Female; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lymph Nodes; Lymphatic Metastasis; Scalp; Skin Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2010
Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck. Oncology reports, 2010, Volume: 24, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Taxoids	2010
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-20, Volume: 28, Issue:36 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Taxoids; Young Adult	2010
[Three cases of adenocarcinoma of the head and neck maintaining QOL by administration of docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:13 Topics: Adenocarcinoma; Adult; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Quality of Life; Taxoids	2010
Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer science, 2011, Volume: 102, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Cell Proliferation; Cisplatin; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunoenzyme Techniques; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2011
Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen. Ear, nose, & throat journal, 2011, Volume: 90, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Scalp; Skin Neoplasms; Taxoids	2011
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2010, Volume: 29, Issue:174 Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Neutropenia; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Vomiting	2010
How does TPF improve survival over PF? The Lancet. Oncology, 2011, Volume: 12, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Randomized Controlled Trials as Topic; Taxoids; Time Factors	2011
How does TPF improve survival over PF? The Lancet. Oncology, 2011, Volume: 12, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Disease-Free Survival; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Lost to Follow-Up; Randomized Controlled Trials as Topic; Research Design; Taxoids	2011
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head & neck, 2011, Volume: 33, Issue:6 Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MicroRNAs; Neoplasms, Squamous Cell; Pharmacogenetics; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Taxoids	2011
[A case of angiosarcoma of the scalp with severe fluid retention after administering docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:5 Topics: Aged; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Docetaxel; Drainage; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Male; Pleural Effusion, Malignant; Scalp; Skin Neoplasms; Taxoids; Tomography, X-Ray Computed	2011
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas. International journal of radiation oncology, biology, physics, 2011, Nov-15, Volume: 81, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Enteral Nutrition; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Radiation-Sensitizing Agents; Taxoids; Weight Loss	2011
Optimizing treatments of locally advanced squamous cell carcinoma: where to go from here? Oral oncology, 2011, Volume: 47, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	2011
Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer model. Oral oncology, 2011, Volume: 47, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Cell Line, Tumor; Cetuximab; Cisplatin; Docetaxel; Drug Therapy, Combination; Fluorouracil; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Mice; Mice, Nude; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays	2011
Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN). Radiation oncology (London, England), 2011, Sep-23, Volume: 6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Middle Aged; Radioimmunotherapy; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome	2011
Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Monitoring; Fever; Fluorouracil; Head and Neck Neoplasms; Humans; Incidence; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Neutropenia; Severity of Illness Index; Survival Analysis; Taiwan; Taxoids	2012
Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy. ACS nano, 2011, Nov-22, Volume: 5, Issue:11 Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Docetaxel; Folic Acid; Folic Acid Transporters; Head and Neck Neoplasms; Humans; KB Cells; Mice; Molecular Targeted Therapy; Nanoparticles; Polymers; Radiation-Sensitizing Agents; Taxoids; Time Factors; Xenograft Model Antitumor Assays	2011
Neoadjuvant chemotherapy prior to surgery in head and neck cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 2012, Volume: 24, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Taxoids	2012
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysis. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cost-Benefit Analysis; Decision Support Techniques; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Induction Chemotherapy; Markov Chains; Monte Carlo Method; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Analysis; Taxoids	2012
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. Cancer research, 2012, Feb-01, Volume: 72, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cells, Cultured; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Endothelial Cells; Gossypol; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Kaplan-Meier Estimate; Male; Mice; Mice, SCID; Neovascularization, Pathologic; Neovascularization, Physiologic; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays	2012
Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer. Advances in therapy, 2012, Volume: 29, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Palliative Care; Remission Induction; Retrospective Studies; Survival Rate; Taxoids	2012
A rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012, Apr-15, Volume: 893-894 Topics: Chromatography, Liquid; Docetaxel; Drug Stability; Head and Neck Neoplasms; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids	2012
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. Journal of cellular physiology, 2013, Volume: 228, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Quinolones; ras Proteins; Signal Transduction; Taxoids	2013
Angiosarcoma of the scalp diagnosed by the presence of neck inflammation: a case report. International journal of oral science, 2012, Volume: 4, Issue:3 Topics: Aged; Antineoplastic Agents; Cranial Irradiation; Docetaxel; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lymphatic Metastasis; Male; Neck; Positron-Emission Tomography; Radiography; Scalp; Skin Neoplasms; Taxoids; Ultrasonography	2012
Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection. Oral oncology, 2013, Volume: 49, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Radiotherapy, Conformal; Remission Induction; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome	2013
Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta oto-laryngologica, 2012, Volume: 132, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Risk Assessment; Salvage Therapy; Survival Analysis; Taxoids; Tongue; Tongue Neoplasms; Treatment Outcome	2012
Digestive symptoms as side effects of combination chemotherapy of docetaxel, nedaplatin and 5-fluorouracil for head and neck cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Neoplasm Grading; Organoplatinum Compounds; Retrospective Studies; Taxoids	2012
Induction docetaxel, Cisplatin, and 5-Fluorouracil precludes definitive chemoradiotherapy in a substantial proportion of patients with head and neck cancer in a low socioeconomic status population. American journal of clinical oncology, 2014, Volume: 37, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Medicaid; Middle Aged; Mississippi; Retrospective Studies; Social Class; Taxoids; Treatment Outcome; United States	2014
Hypofractionated palliative radiotherapy for advanced head and neck cancer: the IHF2SQ regimen. Head & neck, 2013, Volume: 35, Issue:12 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Palliative Care; Radiotherapy; Retrospective Studies; Sex Factors; Taxoids	2013
The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:6 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Neoadjuvant Therapy; Neoplasms; Paclitaxel; Taxoids	2002
Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:12 Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; DNA Primers; Docetaxel; Endothelial Growth Factors; fas Receptor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Taxoids; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer, 2003, Jan-15, Volume: 97, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Leucovorin; Paclitaxel; Radiotherapy, Adjuvant; Survival Analysis; Taxoids; Treatment Failure; Treatment Outcome	2003
[Two patients with distant metastases from head and neck squamous cell carcinomas successfully treated with docetaxel and cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Paclitaxel; Remission Induction; Taxoids	2003
[Combined usage of taxotere in induction chemotherapy of head and neck neoplasms]. Ai zheng = Aizheng = Chinese journal of cancer, 2003, Volume: 22, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Taxoids	2003
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Coloring Agents; DNA-Binding Proteins; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Oligonucleotides, Antisense; Phosphotyrosine; Signal Transduction; STAT3 Transcription Factor; Taxoids; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Vascular Endothelial Growth Factor A	2003
Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell cycle (Georgetown, Tex.), 2004, Volume: 3, Issue:4 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cell Line, Tumor; Combined Modality Therapy; Cytochromes c; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; G2 Phase; Head and Neck Neoplasms; Immunohistochemistry; In Situ Nick-End Labeling; Kinetics; Mice; Mice, Nude; Microscopy, Fluorescence; Mitosis; Neoplasm Transplantation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Taxoids; Time Factors; Up-Regulation	2004
Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer. The Laryngoscope, 2004, Volume: 114, Issue:11 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Enterovirus; Genetic Therapy; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Protein Biosynthesis; Taxoids; Transduction, Genetic; Tumor Suppressor Protein p53	2004
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)]. Nihon Jibiinkoka Gakkai kaiho, 2005, Volume: 108, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Taxoids	2005
Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head. The British journal of dermatology, 2005, Volume: 152, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Fatal Outcome; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Male; Taxoids	2005
An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma. Archives of otolaryngology--head & neck surgery, 2005, Volume: 131, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Mice; Mice, Inbred BALB C; Mice, SCID; Taxoids	2005
[An autopsied case of metastatic endocrine carcinoma of the pancreas with primary site difficult to identify]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Paclitaxel; Pancreatic Neoplasms; Taxoids	2005
Acute toxicity and preliminary clinical outcomes of concurrent radiation therapy and weekly docetaxel and daily cisplatin for head and neck cancer. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:11 Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Radiotherapy, Conformal; Taxoids; Treatment Outcome	2005
[Weekly docetaxel treatment for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neutropenia; Taxoids; Thrombocytopenia	2005
Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study. The Laryngoscope, 2005, Volume: 115, Issue:11 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA, Neoplasm; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; In Vitro Techniques; Pilot Projects; Signal Transduction; Taxoids; Thrombospondins	2005
Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors. Statistics in medicine, 2006, Aug-15, Volume: 25, Issue:15 Topics: Algorithms; Antineoplastic Agents; Bayes Theorem; Clinical Trials, Phase II as Topic; Computer Simulation; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Leiomyosarcoma; Organoplatinum Compounds; Oxaliplatin; Sample Size; Taxoids	2006
[Intra-arterial chemotherapy for head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Radiotherapy Dosage; Taxoids	2005
[Combination therapy with TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Oxonic Acid; Pyridines; Taxoids; Tegafur	2005
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck. Archives of otolaryngology--head & neck surgery, 2006, Volume: 132, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome	2006
[A combination study of S-1 and docetaxel in patients with head and neck cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 1 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Head and Neck Neoplasms; Humans; Maximum Tolerated Dose; Oxonic Acid; Taxoids; Tegafur	2006
[Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydrocortisone; Infusions, Intra-Arterial; Male; Middle Aged; Remission Induction; Survival Rate; Taxoids; Tongue Neoplasms	2006
Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma. Cancer science, 2006, Volume: 97, Issue:10 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Resistance, Neoplasm; ErbB Receptors; Fluorouracil; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Molecular Sequence Data; RNA, Small Interfering; Taxoids; Xenograft Model Antitumor Assays	2006
Basal cell carcinoma metastatic to cervical lymph nodes and lungs. Dermatology online journal, 2006, Oct-31, Volume: 12, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Basal Cell; Carcinoma, Papillary; Deoxycytidine; Diagnostic Errors; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Radiotherapy; Seminoma; Skin Neoplasms; Taxoids; Testicular Neoplasms; Thyroid Neoplasms; Thyroidectomy; Unnecessary Procedures	2006
Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. Head & neck, 2007, Volume: 29, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Endoscopy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Prognosis; Remission Induction; Taxoids	2007
Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. International journal of oncology, 2007, Volume: 30, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Estradiol; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Transplantation; RNA, Messenger; Salivary Gland Neoplasms; Taxoids	2007
Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, May-15, Volume: 13, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Docetaxel; ErbB Receptors; Gefitinib; Head and Neck Neoplasms; Humans; Microtubules; Mitosis; Pyrazoles; Quinazolines; Sulfonamides; Taxoids	2007
Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation. European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:10 Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Docetaxel; Drug Synergism; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Interleukin-6; Ki-67 Antigen; Resting Phase, Cell Cycle; Serotonin; Taxoids; Tumor Cells, Cultured	2007
[Head and neck: intra-arterial chemotherapy and combined radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Survival Rate; Taxoids	2007
Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines. Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Pyrazines; Taxoids	2008
Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN). Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Tolerance; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Taxoids; Treatment Outcome	2007
Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck. The Journal of laryngology and otology, 2008, Volume: 122, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Survival Rate; Taxoids; Treatment Outcome	2008
Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Molecular pharmacology, 2008, Volume: 73, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Mice, Nude; Models, Biological; Oligonucleotides, Antisense; Oncogene Protein v-akt; Random Allocation; Statistics as Topic; Taxoids; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays	2008
The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics. Oncology research, 2007, Volume: 16, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Calcitriol; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; Dihydroxycholecalciferols; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Ergocalciferols; G1 Phase; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Resting Phase, Cell Cycle; Taxoids	2007
Chemotherapy in unresectable head and neck cancer. The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Radiotherapy; Survival Analysis; Taxoids	2008
Treatment of head and neck cancer. The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngectomy; Larynx; Survival Analysis; Taxoids	2008
Treatment of head and neck cancer. The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Survival Rate; Taxoids	2008
Treatment of head and neck cancer. The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Survival Analysis; Taxoids	2008
Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma. Anti-cancer drugs, 2008, Volume: 19, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Antagonism; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Quinazolines; Taxoids	2008
The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts. Cancer letters, 1994, Jun-30, Volume: 81, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line; Cisplatin; Docetaxel; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Taxoids	1994
Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Clinical Trials, Phase III as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Paclitaxel; Taxoids; Treatment Outcome	1996
Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled? Current opinion in oncology, 2000, Volume: 12, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation-Sensitizing Agents; Taxoids	2000
Docetaxel and cisplatin in head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diuretics; Docetaxel; Head and Neck Neoplasms; Humans; Kidney Tubules; Magnesium; Magnesium Deficiency; Paclitaxel; Taxoids	2000
Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ). International journal of cancer, 2001, Mar-15, Volume: 91, Issue:6 Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Taxoids; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2001
A preclinical model for experimental chemotherapy of human head and neck cancer. International journal of oncology, 2001, Volume: 18, Issue:6 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Ifosfamide; Methotrexate; Mice; Mice, Nude; Paclitaxel; Survival Rate; Taxoids	2001
Highlights of the Eighth European Cancer Conference. Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:11 Topics: Amifostine; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Docetaxel; Head and Neck Neoplasms; Humans; Irinotecan; Neoplasms; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Taxoids; Vinblastine; Vinorelbine	1995
A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck. Farmaco (Societa chimica italiana : 1989), 2001, Volume: 56, Issue:9 Topics: Antineoplastic Agents; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Combined Modality Therapy; Docetaxel; Half-Life; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Paclitaxel; Taxoids	2001
Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Middle Aged; Paclitaxel; Taxoids; Treatment Failure	2002